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ABSTRACT 
 
Bisphenol A (BPA) is an endocrine disrupting chemical widely used in the manufacturing of 
commonly used consumer products containing polycarbonate plastics, epoxy resins, dental sealants, and 
receipt paper. During a process called leaching, the ester bonds maintaining BPA polymers can break, 
releasing BPA into food and beverages, onto skin, into the air, or into the environment.  Studies indicate 
that BPA, with a half-life of at least 4-6 hours, is present in 95% of random urine samples, indicating that 
humans are constantly exposed to this chemical.  Once in the body, BPA can readily mimic, enhance, or 
inhibit normal endocrine responsive processes such as ovarian follicle growth and steroidogenesis. 
Follicles are the functional units of the ovary, responsible for ovulating an oocyte and producing 
sex steroid hormones during steroidogenesis.  Follicles grow and develop from primordial, primary, pre-
antral, and finally, to antral follicles over the course of the female reproductive life.  Further, over time, 
follicles not marked for ovulation undergo atresia, a normal process of follicular cell death.  Disturbances 
in follicle growth or atresia could impair healthy oocyte development and ovulation, ultimately affecting 
fertility.  
 Steroidogenesis is required for healthy development and functioning of various physiological 
systems such as the neural, cardiovascular, and reproductive systems.  Steroidogenesis occurs in pre- 
and antral follicles, though the majority of hormone production occurs in antral follicles.  Cholesterol is 
metabolized into sex steroid hormones such as progesterone, testosterone, and estradiol in the theca 
and granulosa cell layers.  Disturbances in steroidogenesis could impair overall female physiological 
health, as well as impair reproduction. 
 Though many studies have investigated the adverse effects of BPA, few studies have evaluated 
the effects of BPA on antral follicles. Thus, the goal of my dissertation work was to determine the 
toxicity of BPA on adult antral follicles.  Specifically, I examined whether and how BPA affects follicle 
growth, atresia, and steroidogenesis in adult antral follicles.   
 First, I tested the hypothesis that postnatal BPA exposure inhibits antral follicle growth and 
steroidogenesis. I found that BPA inhibited follicle growth and steroidogenesis independently of each 
other.  Additionally, I found that co-culturing follicles with the hormone precursor, pregnenolone, 
partially protected the follicles from BPA-inhibited hormone production, indicating that BPA may be 
targeting rate-limiting enzymes in the estradiol biosynthesis pathway.  Next, I tested the hypothesis that 
BPA alters cell cycle regulators and induces atresia in antral follicles via the genomic estrogenic pathway, 
inhibiting follicle growth.  I found that BPA up-regulated the pro-atresia factor Bax, inducing atresia in 
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antral follicles.  Further, I found that BPA did not inhibit follicle growth or induce atresia through the 
genomic estrogenic pathway, though BPA altered expression of estrogen receptors 1 and 2 over time. 
Finally, I tested the hypothesis that BPA reversibly targets cytochrome P450 side chain cleavage 
(Cyp11a1) and steroidogenic acute regulatory protein (StAR), leading to a decrease in hormone levels.  I 
found that BPA initially targets and decreases expression of Cyp11a1, leading to a decrease in the 
expression of StAR and hormone production.  Further, removal of BPA restored expression of Cyp11a1 
to control levels and prevented down-regulation of StAR and decreases in hormone production.  
Collectively, these data indicate that BPA inhibits follicle growth, induces atresia, and reversibly 
decreases steroidogenesis by targeting rate-limiting enzymes in the estradiol biosynthesis pathway of 
adult antral follicles.   
 
 
 
TABLE OF CONTENTS 
Chapter I     Overview.............................................................................................................................. 1 
1.1 Overview ........................................................................................................................................... 1 
1.2 Figures and Legends .......................................................................................................................... 5 
1.3 References......................................................................................................................................... 9 
 
Chapter II    Introduction ....................................................................................................................... 10 
2.1 Introduction .................................................................................................................................... 10 
2.2 References....................................................................................................................................... 30 
 
Chapter III   Bisphenol A inhibits follicle growth and steroidogenesis in cultured mouse antral follicles
.............................................................................................................................................................. 37 
3.1 Abstract ........................................................................................................................................... 37 
3.2 Introduction .................................................................................................................................... 38 
3.3 Materials and Methods .................................................................................................................... 40 
3.4 Results ............................................................................................................................................. 43 
3.5 Discussion ........................................................................................................................................ 45 
3.6 Tables, Figures, and Legends ............................................................................................................ 47 
3.7 References....................................................................................................................................... 54 
 
Chapter IV   Bisphenol A alters cell cycle regulators and induces atresia in cultured mouse antral 
follicles independently of the genomic estrogenic pathway, inhibiting follicle growth ..... 57  
4.1 Abstract ........................................................................................................................................... 57 
4.2 Introduction .................................................................................................................................... 58 
4.3 Materials and Methods .................................................................................................................... 60 
4.4 Results ............................................................................................................................................. 64 
4.5 Discussion ........................................................................................................................................ 67 
4.6 Figures and Legends ........................................................................................................................ 70 
4.7 References....................................................................................................................................... 82 
 
Chapter V    BPA acutely and reversibly down-regulates Cyp11a1, leading to a reversible decrease in 
sex steroid hormone production in cultured mouse antral follicles  .................................. 86 
5.1 Abstract ........................................................................................................................................... 86 
5.2 Introduction .................................................................................................................................... 87 
5.3 Materials and Methods .................................................................................................................... 89 
5.4 Results ............................................................................................................................................. 92 
5.5 Discussion ........................................................................................................................................ 94 
5.6 Figures and Legends ........................................................................................................................ 97 
5.7 References..................................................................................................................................... 102 
 
Chapter VI   Summary, conclusions, and future directions .................................................................. 105 
6.1 Summary, Conclusions, and Future Directions ............................................................................... 105 
6.2 Figures and Legends ...................................................................................................................... 108 
6.3 References..................................................................................................................................... 109 
 
  
1 
 
 
CHAPTER I 
 
Overview 
 
1.1 Overview 
Bisphenol A (BPA) is a synthetic estrogen used in the manufacturing of common consumer 
goods such as polycarbonate plastics, epoxy resins, and receipt paper (Figure 1.1).  Once released from 
these products, BPA readily enters the body via ingestion, inhalation, or dermal absorption.  In the body, 
BPA can act as an endocrine disrupting chemical, mimicking, inhibiting, or enhancing natural hormonal 
processes required for reproduction.  In a government funded human study (National Health and 
Nutrition Examination Survey), BPA was present in 95% of random urine samples, indicating that 
humans are constantly exposed to this chemical [1].    
BPA has also been detected in ovarian follicular fluid of adult women [2], indicating that BPA is 
able to reach the ovary.  Thus, it is possible that BPA can adversely affect the ovary.  In fact, some 
studies have shown that BPA may impair oocyte retrieval in humans and impair meiotic progression and 
spindle formation in oocytes in animals [3;4;5].  Additionally, BPA exposure has been shown to impair 
oocyte ovulation, increasing the amount of follicular cysts present in ovaries of animals [6;7], and may 
be associated with the presence of PCOS in women [8].  However, few studies have investigated the 
effects of BPA on follicles and even fewer studies have focused on the antral follicles. 
Follicles are the functional units of the ovary.  Follicles grow and develop from primordial 
follicles to antral follicles throughout the reproductive lifespan of a female (Figure 1.2).  Antral follicles 
are characterized by the presence of a fluid filled antrum, a single oocyte, multiple layers of granulosa 
cells, and a double layer of theca cells.  Antral follicles are the only follicles capable of ovulation and the 
main producers of sex steroid hormones in females (Figure 1.3).  Some studies have shown that BPA can 
alter hormone production in isolated theca and granulosa cells [9], but it is unknown how BPA affects 
steroidogenesis in the intact, adult, antral follicle.  Further, no studies have determined how BPA affects 
intact, adult antral follicle growth.  Thus, the overall goal of my doctoral dissertation work was to 
broaden our understanding of whether BPA exposure is toxic to antral follicles, and to determine the 
mechanism by which BPA induces toxicity in intact, adult, antral follicles (Figure 1.4). 
To do this, I specifically tested four main hypotheses: 1) Postnatal BPA exposure inhibits follicle 
growth and steroidogenesis in intact antral follicles, 2) BPA inhibits adult antral follicle growth by 
altering cell cycle regulators and inducing atresia in antral follicles, independent of the genomic 
estrogenic pathway, 3) BPA inhibits steroidogenesis in the adult antral follicle by down-regulating 
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Cyp11a1, and 4) BPA-induced inhibition of steroidogenesis is reversible.  To these hypotheses, I 
completed the following specific aims: 
 
Specific Aim 1: To determine if postnatal BPA exposure inhibits antral follicle growth and 
steroidogenesis. 
To complete this aim, I cultured mouse antral follicles with vehicle control (dimethylsulfoxide; 
DMSO), BPA (1, 10, and 100µg/mL), pregnenolone (10µg/mL), or pregnenolone+BPA for 120 hours (h).  
Then, I examined the effects of BPA alone and the effects of co-treatment with BPA and pregnenolone 
on follicle growth, expression of steroidogenic enzymes, and hormone production.  Collectively, my data 
indicate that BPA (100µg/mL) significantly inhibits antral follicle growth beginning at 72h and continuing 
throughout culture.  Additionally, BPA (10 and 100µg/mL) significantly inhibits hormone production in 
antral follicles.  Further, co-treatment with BPA (10 and 100µg/mL) and pregnenolone (10µg/mL) 
partially protects the antral follicles from BPA-induced inhibition of hormone production, without 
protecting the antral follicles from BPA-induced inhibition of follicle growth.  These data are presented 
in Chapter 3. 
 
Specific Aim 2: To determine if BPA alters cell cycle regulators and induces atresia in antral follicles via 
the genomic estrogenic pathway, inhibiting follicle growth.  
To complete this aim, I cultured mouse antral follicles with vehicle control (DMSO) and BPA (1, 
10, and 100µg/mL) for 24 to 120h (h).  Then, I examined the effects of BPA on the expression of select 
cell cycle regulators, expression of select atresia factors, and atresia in conjunction with follicle growth 
every 24h of culture.  The data indicate that BPA (100µg/mL) aberrantly up-regulates expression of cell 
cycle regulators cyclin dependent kinase 4 (Cdk4), cyclin e1 (Ccne1), and tumor protein p53 (Trp53), as 
well as atresia factors B-cell lymphoma factor 2 (Bcl2), and Bcl2-associated X factor (Bax). Additionally, 
BPA (100µg/mL) induces atresia in antral follicles beginning at 48h and continuing at 120h.  Collectively, 
my data indicate that BPA affects factors controlling follicle growth and atresia prior to inhibiting follicle 
growth at 72h.  These data are presented in Chapter 4. 
Further, I cultured mouse antral follicles from both control mice and estrogen-receptor 
overexpressing mice (OE) with vehicle control (DMSO), BPA (1, 10, and 100µg/mL), estradiol (10nM), ICI 
(1µM), estradiol+BPA, and ICI+BPA.  Then, I examined the effects of BPA on follicle growth via the 
estrogenic pathway. Collectively, my data indicate that neither co-treatment with estradiol nor ICI 
protects the follicles from inhibited follicle growth or atresia.  Moreover, overexpression of estrogen 
3 
 
 
receptor 1 does not increase the sensitivity of antral follicles to the effects of BPA.  These data are 
described in Chapter 4. 
 
Specific Aim 3: To determine if BPA first decreases the mRNA expression levels of the steroidogenic 
enzyme cytochrome P450 side-chain cleavage (Cyp11a1) and steroidogenic acute regulatory protein 
(StAR) in mouse antral follicles, leading to a decrease in sex steroid hormone production in vitro.   
 To complete this aim, I cultured mouse antral follicles with vehicle control (DMSO) and BPA (1, 
10, 100µg/mL) for 6 to 96h.  Then, I examined the effects of BPA on steroidogenic enzyme expression 
and hormone production over time.  Collectively, my data indicate that BPA down-regulates expression 
of Cyp11a1 after 18h in culture, prior to inhibiting the expression of StAR and hormone production in 
antral follicles after 24 to 72h in culture.  These data are described in Chapter 5. 
 
Specific Aim 4: To determine if BPA acutely and reversibly decreases the mRNA expression levels of 
the steroidogenic enzyme cytochrome P450 side-chain cleavage (Cyp11a1) and steroidogenic acute 
regulatory protein (StAR) in mouse antral follicles, leading to an acute and reversible decrease in sex 
steroid hormone production in vitro.    
 To complete this aim, I cultured mouse antral follicles with vehicle control (DMSO) and BPA (1 
and 10µg/mL) for 20 to 96h.  At 20h in culture, I replaced BPA-containing media with DMSO containing 
media and continued culture up to 24 to 96h total culture time.  Then, I examined the effects of BPA 
removal on steroidogenic enzyme expression and hormone production over time.  Collectively, my data 
indicate that BPA acutely and reversibly down-regulates the expression Cyp11a1 and inhibits hormone 
production.  Specifically, by 48h and continuing throughout culture, expression of Cyp11a1 and levels of 
progesterone return to control levels and expression of StAR never decreases.  Further, levels of 
androstenedione, testosterone, and estradiol are never inhibited.  These data are described in Chapter 
5. 
In summary, in chapter 1, I have described the overview for my dissertation.  In chapter 2, I 
describe the background of my dissertation work.  In chapter 3, I describe the work that relates to the 
hypothesis that BPA inhibits antral follicle growth and steroidogenesis.  In chapter 4, I describe the work 
that relates to the hypothesis that BPA inhibits adult antral follicle growth by altering cell cycle 
regulators and inducing atresia in antral follicles, independent of the genomic estrogenic pathway.  In 
chapter 5, I describe the work that relates to the hypothesis that BPA inhibits steroidogenesis in the 
adult antral follicle by down-regulating Cyp11a1.  Additionally, in chapter 5, I describe the work that 
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relates to the hypothesis that BPA-induced inhibition of steroidogenesis is reversible.  In chapter 6, I 
summarize the findings of my dissertation work, discuss potential pitfalls, and suggest future research 
directions. 
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1.2 Figures and Legends 
 
Figure 1.1 Chemical structure of Bisphenol A (BPA) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BPA is made of two bisphenol rings separated by two methyl groups.  Polycarbonate is formed by joining 
multiple BPA monomers by ester bonds.  
6 
 
 
Figure 1.2 Folliculogenesis 
 
 
 
The ovary consists of follicles at different stages of folliculogenesis.  The earliest stage is the primordial 
follicle, followed by the primary, preantral, and, finally, the antral follicle.   
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Figure 1.3 Estradiol biosynthesis pathway 
 
 
 
In the theca cells, cholesterol is transported into the inner mitochondrial membrane by steroidogenic 
acute regulatory protein (StAR) where it is converted to pregnenolone by cytochrome P450 side-chain 
cleavage (Cyp11A1).  Pregnenolone is then converted to progesterone, dehydroepiandrosterone, 
androstenedione, and testosterone by various steroidogenic enzymes.  Androstenedione and 
testosterone diffuse into the granulosa cells, where they are further metabolized into estrone and 
estradiol.    
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Figure 1.4 Model of BPA action in adult antral follicles 
 
The model depicts the proposed mechanism of BPA action in adult antral follicles.  I propose that BPA 
inhibits follicle growth by decreasing the expression of cell cycle regulators, induces atresia by up and 
down-regulating pro- and anti-atretic factors, respectively, and decreases hormone production by 
decreasing the expression of steroidogenic enzymes in the estradiol biosynthesis pathway.  
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CHAPTER II 
 
Introduction 
 
2.1 Introduction 
In 2007, an expert panel was created to review the association between BPA exposure and 
reproductive health outcomes [1].  At that time, laboratory animal studies involving BPA exposure were 
completed, but very few human epidemiology or clinical studies were performed.  Further, the animal 
studies differed drastically from each other in terms of animal strain, dosage, and exposure route.  This 
made it difficult to compare results from animal studies and correlate them with human health trends.  
Despite this, the panel came to some conclusions about the strengths and weaknesses of the laboratory 
animal studies. The panel also created guidelines for future in vivo and in vitro studies that would allow 
for comparisons across species, strains, doses, and exposure routes in hopes that animal studies could 
be related with each other and extrapolated to human health outcomes.  While laboratory studies are 
essential for exploring systemic effects and mechanisms of action, the panel recognized that there are 
limitations to extrapolating animal studies to human health trends. The individual animal studies that 
should include exposure routes similar to human exposure, such as oral or dietary dosing.  Additionally, 
the doses should be relevant to human exposure, and include the concentrations of BPA detected in 
human tissues and fluids.  Therefore, with these guidelines and following an NIEHS initiative to fund 
research programs studying the effects of BPA exposure on human health, several new studies on the 
impact of BPA on the reproductive system have been conducted and reported.  This current review 
summarizes the findings since the publication of the expert panel in 2007. 
 The safety of BPA has been in question because the regulatory guidelines set for the safety of 
BPA were based on results from high-dose studies.  Using the dogma of toxicology, ‘the dose makes the 
poison,’ if no adverse health effects were seen at high doses, then no effects would be seen at low 
doses.  However, BPA does not follow a linear dose response curve; BPA is non-monotonic at best, while 
occasionally following inverted and U-shaped curve responses. As such, BPA could have different effects 
at various doses, high and low.  Additionally, sensitivity to BPA and longevity of an effect is dependent 
on life stage and time of exposure.  While results from postnatal and adult exposure studies are not 
indicative of gestational exposure effects, it is highly likely that early exposure to BPA could affect health 
outcomes as an adult, even without on-going or persistent exposure.  Moreover, it is well established 
that known sources of BPA are not satisfactory enough to explain measured human levels of BPA.  
Human concentrations of BPA are widespread and are variable, with varying levels (0.3 to /mL (ppb)) in 
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tissues and fluids from fetuses, children, and adults.  Thus, BPA may accumulate in the tissues to be 
released at later time-points, rather than exerting its effects during acute exposure.   Finally, the effects 
of BPA may be tissue specific; a certain dose of BPA may affect the ovary differently than the uterus or 
the liver or the kidney.  Therefore, a thorough investigation of how BPA affects different tissues in a 
variety of species and at a wide range of doses and exposure routes is necessary to assess the potential 
hazards to human health and emerging human health trends.  
 Thus, in this review, I have included detailed information about the effects of BPA on a variety of 
reproductive issues, taking into account species, dose, route of exposure, and timing of exposure.   I also 
included details on human studies of BPA and information on whether the human and animals studies 
are consistent.  Finally, I included information about the mechanisms of BPA action from both in vitro 
and in vivo studies.   
 
Female Reproductive System 
 The female reproductive system is composed of the ovaries and accessory sex organs, such as 
the oviduct, uterus, and placenta.  BPA has the potential to target each of these tissues.  The section 
below summarizes what is known about the effects of BPA on the ovaries, oviduct, uterus, and placenta 
in a variety of species. 
 
Effects of BPA on the Ovary 
 The ovaries consist of developing follicles, which house the female gametes (oocytes).  Follicles 
are the functional units of the ovary and are absolutely required for reproduction.  All female mammals 
are born with a finite number of primordial follicles, which grow to primary, pre-antral, and finally, 
antral follicles.   Primordial follicles consist of a single oocyte surrounded by a single layer of fusiform 
shaped granulosa cells. Primordial follicles develop into primary follicles.  By this time, the oocyte 
enlarges in size and the granulosa cells change from a fusiform to cuboidal shape.  Primary follicles grow 
into pre-antral follicles.  At this time, the granulosa cells rapidly proliferate and the follicles acquire a 
thecal cell layer.  Pre-antral follicles then develop into antral follicles.  During this time, the follicle 
acquires a fluid-filled antral cavity called the antrum, the granulosa cells continue to proliferate, and the 
thecal cells become more mature.  Antral follicles are the only follicles capable of ovulating the oocyte.  
Maturation of the follicles is a continuous event throughout the reproductive lifespan of female.  
  The ovaries are the main producers of sex steroid hormones.   Specifically, hormones are 
produced by a combined effort of the theca and granulosa cells in pre- and antral follicles.  Briefly, 
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cholesterol present in the mitochondria of theca cells is converted to pregnenolone by cytochrome P450 
side chain cleavage (CYP11A1).  Pregnenolone is then converted to progesterone, androgens, and finally, 
estrogens, by steroidogenic enzymes such as 3β-hydroxysteroid dehydrogenase (3β-HSD), cytochrome 
P450 17α (Cyp17α), or aromatase (Cyp19), respectively.  Disruptions in hormone production could be 
due to direct effects on either the granulosa or theca cells, or effects on factors required to produce 
hormones, such as the steroidogenic enzymes. 
 The ovaries may be sensitive to the effects of BPA based on studies reporting alterations in 
ovarian folliculogenesis, steroidogenesis, and ovarian morphology after BPA treatment [2].  Studies on 
the effects of BPA on ovarian morphology are limited and have focused on polycystic ovarian syndrome 
(PCOS).  PCOS is an endocrinopathy characterized by high androgenemia and antral follicle anovulation 
[2].  Antral follicles that do not ovulate and fail to undergo atresia will become non-functional follicular 
cysts.  Polycystic ovaries are identified by numerous follicular cysts [3].  One published epidemiological 
study reported an association between BPA and PCOS [2].  In that cross-sectional study of 71 women 
diagnosed with PCOS, BPA was significantly correlated with the occurrence of PCOS.  Moreover, serum 
BPA concentrations were significantly higher in women with PCOS compared to women without PCOS.  
Given these data, further studies are warranted to establish a more definitive association between BPA 
and polycystic ovaries in women with PCOS. 
 BPA exposure has been linked to similar PCOS-like syndromes in rodents.  An in vivo study found 
that Balb/c mice gestationally exposed to BPA (s.c. injection; 100 or 1000 µg/kg) from GD1 to PND7 had 
a significant increase in cystic ovaries [4].  Gestational and neonatal exposure to BPA (s.c. injection; 0.1, 
1, 10, 100, or 1000 µg/kg) also increased the presence of ovarian cysts in adult CD-1 mice [5].  In SD rats, 
gestational exposure to BPA (s.c. injection; 50µg/50µL) increased the amount of follicular cysts present 
in the adult ovary as well [6].  These data provide strong evidence that gestational exposure to BPA is 
associated with the presence of ovarian follicular cysts in the adult rodent.  
 Multiple studies have investigated the effects of BPA on hormones produced by ovarian follicles 
in humans.  To date, six epidemiological studies have investigated the association between BPA 
concentration and steroidogenesis.  In a prospective preconception cohort study of 147 women 
undergoing IVF, urinary BPA concentrations were significantly associated with decreased levels of 
estradiol [7].  Another prospective cohort study with 84 women also found that increasing serum BPA 
concentrations were associated with decreasing estradiol levels [8].  A cross-sectional study of 44 
women undergoing IVF indicated that serum BPA concentrations were non-significantly and inversely 
associated with estradiol levels, but significantly and inversely associated with peak estradiol levels 
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normalized to follicle size [9]. Additionally, in another cross-sectional study of 100 women eating a high 
carbohydrate diet for 3 days, serum BPA concentration was significantly positively associated with levels 
of testosterone and androstenedione [2].  Conversely, utilizing participants in the INChianti study (2010) 
who refrained from eating meat or fish for 3 days, urinary excretion of BPA was not associated with the 
levels of estradiol or testosterone [10].  However, it is possible that the lack of association was due to 
limited sensitivity of the assay used to measure testosterone in women.  Thus, it is important that future 
studies use sensitive hormone assays to evaluate associations between BPA and hormones.   
 BPA has also been shown to affect ovarian steroidogenesis in laboratory animal studies.  The 
effects, however, are often different than those reported in human epidemiological studies.  In one 
study, BPA (oral gavage; 12 and 25mg/kg) given to mice from gestational day (GD)1 to postnatal day 
(PND)56 increased levels of estradiol and decreased levels of testosterone, while increasing the 
expression of Cyp19 and Cyp11a1  compared to controls [11].  However, in another study, PND30 lambs 
exposed to BPA (i.p. injection; 50µg/kg) from PND1 to PND14 had similar hormone levels to controls 
[12].   
 The effects of BPA on steroidogenesis in various tissues in vitro are also equivocal.  BPA (44 and 
440µM) inhibited estradiol, testosterone, androstenedione, estrone, dehydroepiandrosterone, and 
progesterone production, and decreased expression of StAR and Cyp11a1 in cultured intact murine 
antral follicles [13].  However, BPA (10-7 to 10-4M) increased testosterone synthesis and expression of 
Cyp17a, Cyp11a1, and StAR in isolated murine theca-interstitial cells cultured for 72h [14].  In the same 
culture system, BPA (10−7 to 10−5M) increased progesterone synthesis and expression of Cyp11a1, but 
BPA (10-4M) decreased progesterone synthesis.  Additionally, BPA (10-4M) increased the expression of 
StAR.  Further, BPA (10-6 to 10-4M) inhibited estradiol levels and the expression of Cyp19 in these cells as 
well [14].  Collectively, the lower doses of BPA increased androgen and progesterone production in 
theca-interstitial cells, while the higher doses inhibited progesterone and estradiol production.  
Similarly, low levels of BPA (0.1µM) increased estradiol and decreased progesterone levels, while higher 
levels of BPA (1 and 10µM) decreased estradiol and progesterone levels in porcine granulosa cells 
cultured for 48h [15].  While both human and laboratory animal studies have somewhat conflicting 
results, taken together, these studies indicate that BPA alters hormone production in multiple species.  
More studies are required to understand the mechanism by which it does so and to determine why 
some discrepancies exist in the effects of BPA in different species, in vivo and in vitro.  
 In addition to affecting ovarian morphology and steroidogenesis, other studies indicate that BPA 
may impair germ cell nest breakdown and follicle formation.  Germ cell nest breakdown is the process in 
14 
 
 
which immature germ cells and somatic cells form into primordial follicles.  After proper germ cell nest 
breakdown, each follicle should only have one oocyte.   However, in PND30 lambs neonatally exposed to 
BPA (i.p. injection; 50µg/kg) from PND1 to PND14, BPA increased the amount of multi-oocyte follicles in 
primordial follicles, suggesting inappropriate germ cell nest breakdown [12].  In gestationally exposed 
macaques, BPA (dietary; 400µg/kg) also increased the number of oocytes present in secondary and 
antral follicles at birth [16]. Further, in gestationally exposed PND5 mice, BPA (oral dosing; 0.02, 0.04, or 
0.08 mg/kg) dose dependently increased the number of oocytes in germ cell nests, while decreasing the 
number of primordial follicles in a dose-dependent manner [17].  Collectively, these studies indicate that 
gestational BPA exposure adversely affects germ cell nest breakdown in multiple species. 
 Germ cell nest breakdown leads to follicle formation.  Throughout a reproductive cycle, follicles 
will transition and mature from primordial, to primary, to pre-antral, and finally, to antral follicles.  BPA 
exposure has been shown to accelerate follicle transition in different species.  BPA (i.p. injection; 
50µg/kg) accelerated follicle transitions in PND30 lambs neonatally exposed to BPA from PND1 to 
PND14 by decreasing primordial follicles and increasing primary follicles, without affecting total follicle 
numbers [12].  BPA also increased cell proliferation in small antral follicles in the neonatally exposed 
lambs, confirmed by Ki67 staining [12]. BPA (s.c. injection; 20mg/kg) also accelerated primary follicle 
development, while decreasing the percentage of primordial follicles present at PND8 in Wistar rats 
neonatally exposed on PND 1, 3, 5 and 7 [18].  BPA (20mg/kg) increased the proliferation rate of 
granulosa cells and expression of estrogen receptor β in those recruited follicles as well [18].     
 BPA has also been shown to alter cell-cycle regulators controlling cell proliferation in follicles in 
vitro.  In cultured, intact, murine antral follicles, exposure to BPA (440µM) for 120h aberrantly up-
regulated expression of cell cycle regulators, while also up-regulating pro- and anti- atretic factors Bax, 
P53, and Bcl2, inducing apoptosis and inhibiting follicle growth [19].  Conversely, BPA (440µM) inhibited 
follicle growth and induced apoptosis in the follicles, though this may be in response to aberrantly 
induced cell cycle regulators [13;19].  Taken together, these studies provide convincing evidence that 
BPA impairs germ cell nest breakdown, inappropriately accelerates follicle transitions, and may affect 
cell cycle regulators that control cell proliferation. 
 Disruption of the somatic cells in follicles may lead to disruption of the oocytes because healthy 
somatic cells are required for healthy oocytes.  Multiple, though somewhat conflicting, studies have 
investigated the effects of BPA on oocytes.  To date, four epidemiological studies have investigated the 
association between BPA concentrations and oocyte maturation, fertilization, and retrieval in women.  
In a small prospective study of 58 infertile women and 37 male partners undergoing intracytoplasmic 
15 
 
 
sperm injection (ICSI) or conventional IVF, serum BPA concentrations were not associated with oocyte 
maturation [20].  However, in the study sample, increasing serum BPA concentrations significantly 
decreased the probability of obtaining mature oocytes in Asian women [20].  Additionally, an increasing 
serum BPA concentration was correlated with decreases in the probability of oocyte fertilization in 
couples undergoing IVF for every year increase in female age [20].  In two additional prospective cohort 
studies of 84 women [7] and 147 women [8] in infertile partnerships undergoing IVF, increasing urinary 
BPA concentration was associated with decreased oocyte retrieval.  Increasing BPA concentrations 
decreased the number of oocytes retrieved during IVF by 1 to 24% in one study [8], and by an average of 
12% in the other study [7].  These results provide compelling evidence that BPA impairs oocyte retrieval 
and could impact oocyte maturation and fertilization during IVF treatments.  
 Several conflicting animal studies also indicate that BPA can directly affect the oocyte.  
Specifically, studies have shown that BPA (i.p. injection; 20 and 40µg/kg) inhibited germinal vesicle 
breakdown (GVBD) and, thus, spindle assembly in oocytes cultured ex vivo  from (C57Bl x CBA/Ca) F1 
hybrid mice after exposure to BPA from PND5 until PND20 in 5 day intervals [21].  BPA (oral dosing; 
0.08µg/kg) induced meiotic delay in oocytes from GD15.5 to 19.5 in gestationally exposed CD-1 mice 
and down-regulated expression of meiosis –controlling factor, Stra8 (stimulated by retinoic acid gene 8) 
at GD17.5 [17].  Conversely, expression of Stra8 was increased on GD12.5 in C57Bl/6 mice gestationally 
exposed to BPA (oral dosing; 20ng/g) from GD11 to 12.5 [22]. BPA (oral gavage; 20, 40, and 100ng/g) 
given to (C57Bl x CBA/Ca) F1 hybrid mice from PND22 to PND28 did not impair maturation-competent 
oocyte retrieval, affect germinal vesicle breakdown, or induce congression failure [23].  BPA (0.2 and 
20mg/kg) given orally to 4 or 9 week old superovulated female C57Bl/6 mice did not affect oocyte 
retrieval either [24].  BPA also failed to affect the frequency of those oocytes in metaphase I or II, induce 
aneuploidy in the oocytes or impair fertilization of the oocyte as measured by the frequencies of zygotes 
reaching the first cleavage division [24].  In gestationally exposed rhesus macaques continuously 
exposed via silastic pump in the pregnant female from GD50 to GD100, BPA (2.2 to 3.3ng/mL) increased 
synaptic defects in fetal ovaries [16].   BPA also increased mean MLH1 levels per oocyte and increased 
centromere association in non-homologous chromosomes in those rhesus macaques at 100dpc [16].  
These studies suggest that oocytes are more sensitive to meiotic alterations during gestational BPA 
exposure than during neonatal and adult BPA exposure.  More studies should be performed in light of 
confounding factors such as exposure time, duration, and species. 
 BPA has also been shown to negatively impact oocytes in vitro.  BPA (1 to 30µM) increased 
oocyte degeneration by impairing meiotic progression and thus, it decreased oocyte survival in cultured 
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human fetal oocytes [25]. Further, BPA (10 and 30µM) increased levels of MLH1 foci in cultured oocytes 
[25].  Gene expression analyses in fetal human oocytes also showed the BPA (30µM) altered expression 
of genes mediating double strand break generation, signaling, and repair [26].  In cultured MF-1 mouse 
oocytes isolated from antral follicles and matured in vitro, BPA 10µg/mL (about 43.8µM) significantly 
altered spindle formation, distribution of pericentriolar material at spindle poles, and induced 
congression failure [23].  Additionally, BPA (30µM) impaired spindle alignment and arrested oocytes 
after germinal vesicle breakdown, preventing maturation in follicle enclosed, cultured oocytes from 
adult C57BL/6jxCBA/c mice.  The oocytes also had decreased polar body extrusion [27].  Taken together, 
the epidemiological, in vivo, and in vitro data suggest that gestational and neonatal exposure may 
negatively impact oocytes in the fetuses and developing offspring, and these defects are maintained into 
adulthood.  Further, the data indicate that postnatal and adult BPA exposure does not affect oocyte 
maturation or fertilization. 
 
Effects of BPA on the Oviduct 
 Once ovulated, the oocyte enters the oviduct.  The oviduct is the pathway between the ovary 
and the uterus.  It is in the ampullary portion of the oviduct that ovulated oocytes are fertilized by 
sperm, forming an embryo to implant in the uterus to initiate pregnancy.  Chemicals affecting function 
or morphology of the oviduct will have detrimental effects on the ability of sperm to fertilize the oocyte 
and transport of the embryo to the uterus.   
 Limited data are available about the effects of BPA on the oviduct.  Only one study has shown 
that BPA affects oviduct morphology in the offspring of exposed mice.  All doses of BPA (0.1 to 
1000µg/kg/day) induced progressive proliferative lesions in the oviducts of treated CD-1 mice, but not in 
the controls [5].  Alterations in oviduct morphology could adversely affect the ability of sperm to reach 
and fertilize the oocyte; thus, these data suggest that BPA has the potential to impair oocyte 
fertilization.  Further studies are necessary to confirm these results and should be performed to identify 
the role of the oviduct in BPA-induced adverse reproductive outcomes. 
 
Effects of BPA on Blastocyst and Embryo Development 
 Once ovulated and fertilized in the oviduct, oocytes develop into blastocysts and then embryos 
for implantation into the uterine epithelial lining.  However, very few studies have examined the effects 
of BPA on blastocyst formation and embryo quality.  One prospective preconception cohort study 
showed that urinary BPA concentration was inversely correlated with blastocyst formation among 147 
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women undergoing IVF, but it was not associated with embryo quality [7].  However, in a prospective 
cohort study involving infertile male and female partners undergoing IVF treatment, increasing urinary 
BPA concentrations in the male decreased the odds of having a high embryo cell count and embryo 
fragmentation score, suggesting these embryos were low quality for IVF treatments [28].  Female 
urinary BPA concentrations were not associated with altered embryo quality [28].  Further studies are 
warranted to investigate the relationship between male BPA exposure and lowered embryo quality 
during IVF treatment.   
 To date, no studies have investigated the effects of in vivo or in vitro BPA exposure on blastocyst 
formation, though one in vivo study showed that BPA impaired embryo quality.  Subcutaneous 
injections of BPA (100mg/kg) given to pregnant C57Bl/6 pregnant females from GD0.5 to 3.5 delayed 
embryo development, keeping 60% of embryos in morula stage compared to 100% of embryos in 
blastocyst stage in non-BPA treated mice [29].  More studies are necessary to determine if there is a 
strong association between BPA and both blastocyst formation and embryo quality. 
 
Effects of BPA on the Uterus 
 The uterus is a muscular organ comprised of a fundus, a corpus, and a narrow caudal portion 
termed the cervix.  The functional portion of the uterus is endometrial tissue, complex glandular tissue 
and stroma, which are responsible for creating a healthy environment for embryo implantation and 
sustained pregnancy.  Endocrine disruptors such as BPA that affect uterine responses to hormones 
and/or uterine gross morphology could impair normal uterine functions such as embryo implantation 
and, thus, lead to adverse birth outcomes.   Though the embryo develops on its way from the oviduct to 
the uterus, blastocyst formation and embryo quality are important markers for its ability to implant in 
the uterine epithelium and continue to form the placenta, the physical link between the female and the 
growing offspring.  Almost all materials required for fetal growth and development pass from the 
maternal blood circulation to the fetal blood circulation via the placenta. 
 The uterus is a hormone responsive organ.  Disrupting steroid hormone signaling will disrupt the 
normal functioning of the uterus.  Endometriosis is an estrogen-dependent disease in which the 
endometrium retains the ability respond to estrogens outside of the uterus and this response can be 
exaggerated, leading to proliferation of endometrial like tissues outside of the uterus.  One study has 
investigated the association of serum BPA concentrations and the occurrence of endometriosis.  In a 
case control study of 69 women, serum BPA concentrations were detected in 58 women with diagnosed 
endometriosis, but were absent in 11 women without endometriosis [30].  Though the authors suggest 
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an association between the presence of BPA and endometriosis, this study had a small and limited 
sample size, poor reporting of BPA concentrations, as well as incomplete statistical analyses performed 
on the data.  Thus, further studies are required to confirm the findings.   
 An in vivo study in young adult mice found similar results to the human studies, indicating that 
gestational and early exposure to BPA may lead to endometriosis.  Female Balb/c exposed gestationally 
and neonatally to BPA (100 or 1000µg/kg/day) from GD1 to PND7 developed endometrial like structures 
with glands and stroma in adipose tissue surrounding the genital tract in adulthood.  These endometrial 
structures were confirmed by expression of Hoxa10, a transcription factor that mediates proliferation of 
stromal tissue prior to implantation [4].  Other in vivo studies, though not directly investigating the 
occurrence of endometriosis, have shown that BPA may impair uterine responses to hormones, 
including proliferation of uterine epithelium and stroma.  Multiple studies reported that BPA decreased 
expression of Esr1 in the rodent uterine epithelium and stroma compared to controls without affecting 
PR expression over a wide range of doses (BPA300ng/kg, 50µg/kg, 1.2mg/kg, and 20mg/kg), exposures 
times (GD1-4, GD9-16, GD1-PND21, PND1-7, or adult), and routes of exposure (s.c injection, alzet 
pumps, drinking water) [31-36].  Additionally, in two separate studies, adult Wistar rats neonatally 
exposed to s.c. injections of BPA (0.05 or 20mg/kg) or to BPA (1.2mg/kg) via the drinking water had 
decreased uterine epithelium proliferation in response to hormone replacement treatments compared 
to controls [35;37].  BPA (1.2mg/kg) also impaired apoptosis of the uterine epithelium during estrus in 
neonatally exposed, adult Wistar rats compared to controls [37].   
 BPA has also been shown to impair the proliferation of cultured uterine cells.  BPA (50 and 100 
µmol/L) significantly decreased proliferation of human endometrial stromal fibroblasts cultured for 48h 
compared to controls [34].  Moreover, BPA (50µM) decreased the proliferation of human endometrial 
endothelial cells cultured for 24h compared to controls [38].  Further studies are needed to evaluate if 
BPA similarly impairs the proliferation of uterine cells from laboratory animals.  However, taken 
together with human and in vivo studies, these results indicate that BPA induces an inappropriate 
response of uterine tissues to steroid hormones and impairs proliferation, potentially disturbing normal 
uterine functioning.  
 Studies have also shown that BPA can disturb uterine gross morphology in vivo, creating an 
environment not readily accessible for implanting embryos and, thus, impairing pregnancy initiation.  
BPA (0.1 to 1000µg/kg) induced benign and malignant lesions, such as adenomatous hyperplasia with 
cystic endometrial hyperplasia and atypical hyperplasia, respectively, in gestationally exposed (GD9-16; 
s.c. injection) adult CD1 mice [5] and Balb/c mice (GD1 to PND7; s.c. injection) [4].  Wölffian duct 
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remnants and endometrial polyps were also found in all BPA-exposed mice, whereas these structures 
were absent in the controls [5].  Additionally, BPA (200 and 300ng/kg) injected into pregnant CF1 mice 
from GD1-4 increased luminal area in the uterus, and BPA (300ng/kg) increased luminal cell height, 
suggesting a decrease in uterine receptivity for implanting blastocysts [31]. Further, adult hens exposed 
in ovo on day 4 of incubation to BPA (134µg/g egg) had decreases in the thickness of their tunica 
mucosa and density of uterine glandular structures compared to adult hens not exposed to BPA [4].  
Together, these studies indicate that BPA may be potentially deleterious to embryo implantation by 
impairing the morphology of the uterine epithelium. 
 The uterine epithelium must be receptive to embryo implantation to initiate pregnancy.  In 
several studies, BPA has been shown to impair embryo implantation in the uterus.  Repeated exposure 
to BPA (s.c. injection; 200 300ng/kg and 200 and 300mg/kg) to pregnant CF1 mice on GD1-4 decreased 
the number of implantation sites in the GD6 uterus compared to controls, completely inhibiting all 
embryo implantation [39].  Implantation sites were also decreased in those mice with a single exposure 
to BPA (s.c. injection; 200mg/kg) on GD0 and GD1, but no decrease in implantation occurred with a 
single exposure of BPA on GD2 compared to controls [31;39].  In pregnant C57Bl/6 mice exposed to BPA 
(s.c. injection; 100mg/kg) on GD0.5 to 3.5, all the embryos in the BPA treated group were in the oviduct 
instead of implanting in the uterus as in controls [29]. Interestingly, when untreated and healthy 
embryos were transplanted into the uteri of similarly-treated pseudopregnant C57Bl/6 mice on GD4.5, 
BPA (s.c. injection; 100mg/kg) completely ablated the number of implantation sites in the uteri [29], 
indicating that BPA affects uterine receptivity to implanting embryos, not necessarily the ability of the 
embryos to implant into the uterine epithelium.  In addition to decreasing implantation sites in the 
uterus, BPA (s.c. injection; 20ng/kg; PND1, 3, 5, and 7) decreased pregnancy establishment and 
increased the number of resorption sites in the GD18 uterus of pregnant neonatally exposed Wistar rats 
compared to controls [40].   Remarkably, BPA also increased resorption sites in GD20 uteri of unexposed 
Holtzman female rats mated to neonatally BPA exposed males (s.c. injection; 200-1600µg/kg; PND1-5) 
and increased post-implantation loss compared to controls [41], suggesting male exposure to BPA can 
significantly contribute to adverse reproductive outcomes such as pregnancy loss.  These studies 
strongly suggest that BPA impairs uterine receptivity to hormone stimulation and impairs embryo 
implantation and that BPA exposure could have a negative impact on pregnancy and, thus, 
reproduction.  
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Effects of BPA on the Placenta 
 The placenta is the physical link between mother and offspring.  There are two types of placenta 
in mammals: a yolk sac placenta and a chorioallantoic placenta. The yolk sac placenta functions as a 
nutrient source for the fetus until the chorioallantoic placenta is developed during the fourth week of 
gestation in humans or on GD12 in rodents.  The chorioallantoic placenta morphologically varies among 
species and may or may not be directly connected to the maternal blood system (hemochorial vs non-
hemochorial, respectively).  The layers of the chorioallantoic placenta are formed from trophoblast, 
blastocyst, and endometrial cells, and these cells determine how well the placenta functions and 
exchanges nutrients with the mother.  Disruptions of the placenta can be responsible for failed 
pregnancy initiation and adverse birth outcomes.  However, few studies in humans have been published 
on the association between BPA exposure and alterations in the placenta.  
 Trophoblast proliferation is important for placenta development and establishment in the 
uterine lining.  Some studies have shown that BPA affects placental cell proliferation in vitro.  After 24h 
or 48h of culture, BPA (10-8 to 10-6M) increased apoptosis and decreased cell proliferation of cultured 
human trophoblast cell isolated from first trimester placentas, while BPA 10-5M decreased cell viability 
compared to controls [42].  Similarly, after 24h in culture, BPA (0.02 to 200µg/mL) increased apoptosis in 
cultured human cytotrophoblasts isolated from placentas after normal delivery compared to controls 
[43].  Taken together, these data provide a convincing argument that BPA may contribute to adverse 
birth outcomes in humans, potentially by affecting placental function. 
 
Male Reproductive System 
 The male reproductive system consists of the testes and accessory sex structures such as the 
prostate gland.  BPA has the potential to affect these structures.  The section below summarizes the 
effects of BPA on the testis and the prostate gland.   
 
Effects of BPA on the Testis  
 The testes are responsible for the production, maintenance, and transport of spermatozoa 
within the male reproductive system, as well as the production of sex steroid hormones.   Testes are 
mostly composed of numerous coiled seminiferous tubules and Leydig cells.  Spermatozoa are 
continuously produced in the seminiferous tubules, beginning as testicular stem cells and developing 
into spermatogonium, spermatocytes, and finally, spermatids.   In the spaces between seminiferous 
tubules, Leydig cells produce the majority of sex steroid hormones in the male.  Spermatozoa and 
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proper hormone production are absolutely required for male reproduction.  Disruption in number 
and/or quality of spermatozoa, the Leydig cells, or other supporting structures required for 
reproduction, such as the prostate, will negatively impact fertility. 
 Many studies have shown that exposure to BPA may affect the testis by decreasing sperm 
quality indicators such as concentration, motility, and morphology.  In a cross-sectional study of 190 
male partners of sub-fertile couples seeking IVF treatment, urinary BPA concentration was investigated 
for an association with sperm concentrations, semen quality, and sperm DNA damage.  When semen 
and urine samples were taken at different times of the day, urinary BPA concentration was not 
correlated with sperm concentrations or increased odds of having low sperm quality [44].  However, 
when semen and urine samples were collected at the same time, increasing urinary BPA concentration 
was associated with decreased sperm concentration, motility (including computer-assisted sperm 
analysis motion characteristics straight-line velocity and curvilinear velocity), and morphology.  Urinary 
BPA concentration was also positively associated with increased sperm DNA damage, measured by 
percent of tail damage [44].   Similarly, a cohort study of 218 men showed that men occupationally 
exposed to BPA had a dose-response association between urinary BPA concentration and increased 
odds of having low sperm quality (concentration, count, vitality, and motility) compared to non-
occupationally exposed men [45].  Moreover, men who were environmentally exposed to BPA with 
urinary BPA levels lower than the national average also had decreased sperm concentration and counts 
compared to non-occupationally exposed men [45].   Further, in a prospective cohort study investigating 
the association between BPA and semen quality in 375 fertile men, increasing urinary BPA concentration 
was associated with decreased total sperm count, motile sperm, and seminal volume [46].  Together, 
these studies provide strong data that BPA is associated with decreased sperm quality in men.  
 Some conflicting reports of the effects of BPA on sperm quality exist in laboratory animal 
studies.  One in vivo study found that gestational exposure to BPA (50 and 1000µg/kg) from GD10 to 
GD16 did not affect spermatogenesis in the adult C57BL/6 mouse [47].  Another study found that 
gestational and neonatal exposure to BPA (dietary; 0.003 to 600mg/kg) did not affect sperm quality or 
motility of PND21 CD-1 (Swiss) mice either [48].  However, BPA decreased sperm counts in gestationally 
and neonatally exposed adult CD1 mice (oral gavage; 1 or 10mg/kg; GD1 to PND21) [49], gestationally 
exposed adult ICR mice (s.c. injection; 5 or 50mg/kg; GD7 and 14) [50], and adult Pzh:SFIS mice (drinking 
water; 10-40mg/kg; 14 day exposure) [51].  While BPA did not decrease sperm counts in gestationally 
and neonatally exposed adult LE rats (oral gavage;2-200µg/kg; GD7 to PND18) [52] or SD rats (dietary; 
0.33, 3.3, or 33ppm; GD6 to PND21) [53], BPA decreased sperm counts in the F1 and F2 generations of 
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gestationally and neonatally exposed Holtzman rats (oral gavage; 1.2 or 2.4µg/kg; GD12 to PND21) [54], 
neonatally exposed Holtzman rats (s.c. injection; 100-1600µg/kg; PND1-5) [41], and adult Wister rats 
(s.c. injection; 500µg/kg; 45 day exposure) [55].   BPA decreased sperm motility in adult Pzh:SFIS mice 
(s.c. injection; 40mg/kg; 14 day exposure) [51], gestationally exposed adult ICR mice (s.c. injection; 5 or 
50mg/kg; GD7 and 14) [50], and gestationally and neonatally exposed Holtzman rats (oral gavage; 1.2 or 
2.4µg/kg; GD12 to PND21) [54], and impaired sperm maturity in neonatally exposed Holtzman rats (s.c. 
injection; 100-1600µg/kg; PND1-5) [41].  Additionally, gestational exposure to BPA (silicone tube; 1.2 or 
60µg/mouse; GD 1 to PND28) decreased the amount of seminiferous tubules with elongated spermatids 
present in 4 week old ICR male offspring, suggesting that spermatogenesis may be disrupted as adults 
[56].  Further, after a 2 week exposure, BPA (drinking water; 5-40mg/kg) induced DNA strand breaks in 
adult Pzh:SFIS mice [51], indicating sperm quality was compromised during continuous exposure to BPA.  
These studies, taken in conjunction with the human studies, give some evidence that neonatal and adult 
exposure to BPA disrupts sperm quality indicators including sperm count, motility, and may induce DNA 
damage in sperm, while gestational exposure may not affect sperm quality indicators at all.   
   In addition to affecting sperm quality, BPA has been shown to affect the testis by altering levels 
of hormones in the body.  To date, three epidemiological studies were performed investigating the 
association between BPA exposure and hormone levels.  Cross sectional analyses of 715 male 
participants from the prospective population based InCHIANTI study found that increasing urinary BPA 
concentrations were positively associated with an increase in testosterone levels, though not with 
estradiol levels [10].  Additionally, in a prospective cohort study involving 375 fertile male partners to 
pregnant women, creatinine-adjusted urinary BPA concentration was associated with decreased free 
androgen index (FAI), ratio of FAI to LH, and ratio of free testosterone to LH [46].  Additionally, 
unadjusted urinary BPA concentration was associated with decreased ratios of free testosterone to LH 
and total testosterone to LH [46].  In a cross sectional study of 167 men recruited from an infertility 
clinic, increasing urinary BPA concentration was associated with increasing serum levels of FSH, but 
decreasing levels of inhibin B, the ratio of FSH to inhibin B, and the ratio of estradiol to testosterone 
[57].  However, this study only involved men recruited from an infertility clinic, so levels of hormones 
may have been dysregulated already, making extrapolations of these results to fertile men difficult.  
Urinary BPA concentration was not associated with estradiol or testosterone levels alone in either study 
[46;57].   
 Though some studies are contradictory, several in vivo studies also indicate that BPA decreases 
hormone levels in male animals.  BPA decreased testosterone levels in gestationally and neonatally 
23 
 
 
exposed CD1 mice [(oral gavage; 1 or 10mg/kg; GD1-PND21), (oral gavage; 50mg/kg; GD1 to PND56)] 
[11;49].  However, in C57BL/6 mice gestationally exposed to BPA (oral gavage; 50µg/kg; GD10 to 16), 
testosterone levels were not affected compared to controls [47].  BPA also decreased levels of FSH in 
gestationally and neonatally exposed CD1 mice in adulthood (oral gavage; 0.1 to 10mg/kg; GD1 to 
PND21) [49].  Additionally, BPA decreased testosterone levels in neonatally exposed Holtzman rats (s.c. 
injection; 100-1600µg/kg; PND1-5) [41], gestationally and neonatally exposed Holtzman rats (oral 
gavage; 1.2 or 2.4µg/kg; GD12 to PND21) [54], adult exposed albino rats (oral dosing; 10mg/kg; 14 day 
exposure) [58], and adult exposed Wister rats (oral gavage; 0.005 to 500µg/kg; 45 day exposure) [15].  
Conversely, gestational and neonatal exposure to BPA did not affect testosterone levels in LE rats (oral 
gavage; 2, 20, or 200µg/kg; GD7 to PND18) [52] or SD rats (dietary; 0.33, 3.3, or 33ppm; GD6 to PND21) 
[53].  BPA also decreased levels of FSH and LH in gestationally and neonatally exposed Holtzman rats in 
adulthood [(oral gavage; 1.2 or 2.4µg/kg; GD12 to PND21), (s.c. injection; 400 or 1600µg/kg; PND1-5)] 
[41;54].  In both mice and rats, these BPA-induced decreases in testosterone may occur because BPA 
also has been shown to decrease expression of various steroidogenic enzymes that control sex steroid 
hormone production such as StaR [11;15;49;55], Cyp11a1 [11;55], and Cyp17α [11;55].   It is unclear 
from these data why some, but not all, studies show that BPA decreases hormone levels.  Strain 
differences may play a role in sensitivity to BPA, warranting further studies into the effects of species 
strain on BPA-induced hormone alterations in males. 
 In addition to altering hormone production, some in vivo studies have looked directly at how 
BPA affects Leydig cells, the steroidogenic cells of the testes, and their hormone production.  In 4-week 
old Wistar/ST rats, chronic exposure to BPA (s.c injection; 100 or 200mg/kg) for 6 weeks decreased 
levels of serum and testicular testosterone, LH, expression of steroidogenic enzymes (Cyp17alpha, 
Cyp11a1, StAR), and decreased Leydig cell numbers compared to controls [55].  Conversely, BPA (oral 
gavage; 2.5 or 25µg/kg; GD21 to PND21) increased Leydig cell numbers compared to controls in 
gestationally and neonatally exposed LE rats in adulthood by up-regulating mitogenic factors such as 
PCNA and cyclin D3 [59].  Interestingly, though Leydig cell proliferation increased, expression of 
steroidogenic enzymes decreased and, thus, so did testosterone production in the rats [59].  Similarly, 
BPA (oral gavage; 1-200mg/kg; GD14 to PND0) increased Leydig cell numbers in gestationally exposed 
SD rats in adulthood without affecting serum testosterone levels [60].  Rodent sexual differentiation 
primarily takes place in the neonatal period after birth, thus, the differences in hormone perturbations 
among these studies could be because of exposure time; the first study used gestational and neonatal 
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exposure, while the second study stopped at birth, prior to establishing permanent hormone signaling 
events. 
 Disruptions in hormone production during development, with or without defects in testis 
morphology, could lead to physical abnormalities such as a shortened anogenital distance (AGD) and 
undescended testes, developmental events mediated by androgens.  A retrospective study investigated 
the association between gestational exposure to BPA and altered (AGD) in human offspring.  The study 
used 56 boys who were in utero while one or both parents were employed in BPA exposed occupations 
(exposed) and compared them to 97 boys with parents who were workers in other related industries 
(unexposed controls).  Parental exposure to BPA in utero was dose-dependently associated with 
shortened AGDs in exposed boys compared to unexposed boys; this inverse correlation was 
strengthened with increasing maternal BPA concentrations [61].   Another prospective cohort study 
investigated the association of in utero BPA exposure with occurrence of cryptorchidism (one or both 
undescended testes) in 46 cryptorchid newborns compared to 100 control newborns.  However, the 
concentration of BPA in cordblood samples was not correlated with the occurrence of cryptorchidism in 
newborn males [62].   Interestingly, while BPA levels did not differ between control and cryptorchid CB 
samples, these results indicate that BPA reaches the fetus during gestation and, thus, could affect other 
reproductive outcomes. 
 In several animal studies, BPA did not affect AGD, but did influence testes descent.  In five 
recent studies, BPA did not shorten or elongate AGD in gestationally exposed C57Bl/6 mice [(oral 
gavage; 50 or 1000µg/kg; GD10 to GD16), (dietary; 0.33, 3.3, or 33ppm; GD6 to PND22)] [47;63], LE rats 
(oral gavage; 2, 20, or 200µg/kg; GD7 to PND18) [52], or SD rats (dietary; 0.33, 3.3, or 33ppm; GD6 to 
PND21) [53].  Notably, none of these studies reported androgen deficiencies after exposure to BPA.  In 
one other recent study, gestational exposure to BPA (600mg/kg) decreased absolute AGD in F1 CD-1 
males at birth, though not in the F2 generation and not when normalized to relative body size [48].  
Interestingly, in that study, BPA (dietary; 600mg/kg; pre-breed to PND21) delayed preputial separation 
and increased the incidence of treatment-related, undescended testes in F1 and F2 offspring, a delayed 
developmental effect [48].   Though differing from human data, these studies only looked at gestational 
exposure to BPA, not gestational and neonatal exposure.  Rodent hormone profiles develop neonatally 
compared to full human development in utero, thus, neonatal exposure to BPA may have more 
influence on AGD and testes descent in rodent studies than in human studies.  Future studies should 
take this into account to accurately correlate findings to human data. 
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Effects of BPA on the Prostate Gland 
 The prostate gland is a composite organ of the urethra, Wöllfian ducts, and loose connective 
tissues (mesenchyme) that secretes an alkaline fluid to help preserve the lifespan of the spermatozoa 
before ejaculation.  It also provides 50-70% of the seminal fluid during ejaculation, thus, disruption of 
the prostate could have deleterious effects on sperm quality, lifespan of sperm, as well as efficient 
transport of sperm during ejaculation.    
 No human data have been published on a relationship between BPA exposure and prostate 
gland structure or function.  However, in animal studies, BPA exposure has been shown to have adverse 
effects on the prostate.   BPA (200mg/kg) administered via drinking water to adult SD rats for ten days 
had increased clusterin levels in the prostate gland [64], the most highly expressed gene during the 
onset of rodent prostate cancer.  BPA (10µg/kg) given orally or via s.c. injection to neonatal SD rats on 
PND1, 3, and 5 increased the incidence of the precursor for prostate cancer, prostate intraepthileal 
neoplasia , in these mice during adulthood (28 weeks old) [65].  Further, in rats with induced benign 
prostatic hyperplasia, BPA (10mg/kg) increased prostate gland weight specifically in the ventral prostate 
lobe and it increased relative weight of the dorsolateral prostate lobe [66].  Epithelial cell heights of the 
ventral prostate lobe and dorsolateral prostate lobe were increased as well [66].  BPA also increased 
prostate gland weight in gestationally exposed LE rats (oral gavage; 1.2 or 2.4µg/kg; GD12 to PND21) 
[54].  Taken together, these data strongly suggest that BPA may be associated with prostate disease, 
including prostate cancer, though human studies should be done to correlate animal findings with 
human exposure.  
 
Reproductive Outcomes 
 Successful reproductive outcomes can be measured by various parameters including sexual 
receptivity, sexual dysfunction, gestation length, and successful delivery of offspring, including body 
weight of the offspring as a measure of gestational health.  In addition to affecting reproduction by 
disrupting oocyte maturation and meiotic progression, blastocyst formation, embryo implantation, 
sperm motility and concentration, or uterine receptivity and response to hormones, BPA could be 
associated with reproductive dysfunction leading to impaired fertility.  The sections below summarize 
what is known about the effects of BPA on various reproductive outcomes. 
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Effects of BPA on Sexual Receptivity 
 BPA has been shown to affect reproductive receptivity by affecting factors such as puberty 
onset, estrous cyclicity, and sexual behavior; components of an ability to copulate and reproduce.  In 
gestationally and neonatally exposed LE rats, BPA did not affect the timing of puberty onset, measured 
by vaginal opening (oral gavage; BPA 2, 20, or 200µg/kg; GD7 to PND18) [67].  Conversely, BPA 
accelerated vaginal opening in neonatally exposed ICR mice (s.c. injection; 0.1 to 100mg/kg; PND8) [68], 
SD rats (s.c. injection; 500µg/50µL or 50µg/50µL; PND1 to PND10) [69], and LE rats (s.c. injection; 
50µg/kg; PND0 to PND3) [70].  Moreover, BPA delayed pre-putial separation in gestationally and 
neonatally exposed CD1 Swiss mice (dietary; 3500ppm; GD1 to PND21) as well as their offspring [48].   
Interestingly, these results suggest the neonatal BPA exposure may accelerate puberty in females, but 
delay puberty in males. 
BPA also decreased the time spent in estrus and number of estrous cycles in neonatally exposed 
female ICR mice (s.c. injection; 100mg/kg; PND8) [68] and increased time spent in estrus (continual 
estrus) in neonatally exposed SD rats (s.c. injection; 500µg/50µL; PND1 to PND10) [69].  However, BPA 
did not affect estrous cyclicity in gestationally and neonatally exposed CD1 Swiss mice (dietary; 0.003 to 
600mg/kg; GD1 to PND21) [48] and LE rats (s.c. injection; 50µg/kg or 50mg/kg; PND0 to PND3) [70].  It is 
not clear why these studies are contradictory and future studies to evaluate the effects of BPA on 
estrous cyclicity should be performed.   
Further, BPA had no effect on lordosis behavior in gestationally and neonatally exposed LE rats 
(oral gavage; 2, 20, 200µg/kg; GD7 to PND18) [67] or neonatally exposed female Holtzman rats (s.c. 
injection; 50µg/kg or 50mg/kg; PND0 to PND3) [70].  These data suggest that BPA does not affect sexual 
behavior in a small set of studies, though further studies should be performed to evaluate these effects 
across species, strains, and a range of doses. 
 
Effects of BPA on Sexual Dysfunction 
An inability to copulate will severely hinder reproduction.  To date, one epidemiological study 
has reported an association between BPA exposure and self-reported sexual dysfunction.  That cohort 
study evaluated the relationship between self-reported impaired sexual abilities and BPA exposure in 
184 occupationally exposed males compared to 284 unexposed males as controls.  BPA, measured by 
personal air monitoring, was positively correlated with greater odds of male sexual dysfunction.  These 
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associations were relevant in men working in the exposed plants for one year or less and maintained for 
all additional years of employment.  BPA workers had an increased risk of reduced sexual desire, erectile 
dysfunction, orgasmic difficulty, and reduced overall satisfaction compared to controls [71].   
 Some animal studies have shown that BPA may impair sexual ability as well.  BPA increased time 
taken for copulation in neonatally exposed Holtzman rats (s.c. injection; 200-1600µg/kg; PND1-5) [41] 
and gestationally and neonatally exposed Holtzman rats (oral gavage; 1.2 or 2.4µg/kg; GD12 to PND21) 
[54].  However, further studies are warranted to evaluate the effects of BPA on sexual ability and, 
potentially, sexual dysfunction across species and strains used in animal studies.   
 
Effects of BPA on Gestation Length 
Carrying pregnancies to term is important for the overall health and development of the 
offspring.  Several studies have evaluated the association between BPA and gestation length.  A pilot 
nested case control study involving 60 pregnant women participating in the Early Life Exposure in 
Mexico to Environmental Toxicant (ELEMENT) study, evaluated the association between BPA and pre-
term birth.  High serum BPA concentrations were associated with increased odds of women delivering 
prior to their 37th week of pregnancy compared to women delivering after the 37th week with lower 
serum BPA concentrations [72].   
  Conversely, in animal studies, BPA did not alter gestation length in gestationally and neonatally 
exposed C57BL/6J mice (dietary; 0, 0.33, 3.3, or 33 ppm; GD6 to PND21) [63], adult CD1 (Swiss) mice 
(dietary; 0.003, 0.03, 0.3, 5, 50, or 600 mg BPA/kg; pre-breed to PND21) [48], or gestationally and 
neonatally exposed SD rats (dietary; 0, 0.33, 3.3, or 33 ppm; GD6 to PND21) [53].  These studies indicate 
that BPA may not affect gestation length in animal models, but may impact gestational length in 
humans.   
 
Effects of BPA on Successful Delivery of Offspring  
 Successful delivery of offspring depends on proper pregnancy initiation and maintenance.  The 
number of litters and live offspring delivered could be affected by embryo implantation in the uterus 
and placenta establishment.  The effects of BPA on the number of litters delivered are unclear.  BPA 
decreased the number of pregnancies established in gestationally and neonatally exposed CD1 mice 
(Alzet osmotic pump; 25ng/kg or 25µg/kg; GD8 to PND16) [73], and decreased the number of successful 
deliveries in these mice.  BPA also decreased the percent of hatchings of White Leghorn chickens 
exposed in ovo to BPA 67 or 134µg/g/egg on day 4 on incubation [74].  Additionally, while BPA also 
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decreased the number of litters born to gestationally and neonatally exposed CD1 mice (Alzet osmotic 
pump; 25ng/kg or 25µg/kg; GD6 to PND18) [73], BPA did not affect the number of litters born to 
unexposed female SD rats mated to gestationally exposed male SD rats (oral gavage; 1-200mg/kg; GD14 
to birth) [60], suggesting that maternal BPA exposure may influence fecundity and fertility, but not male 
exposure.    
Many studies in both mice and rats have reported that BPA had no effect on the number of live 
pups [49;52;53;60;63] or total delivered pups [48;49;53;59;63]. In a few studies, however, BPA had 
different results.  BPA has been shown to decrease the number of live pups born to gestationally and 
neonatally exposed CD1 mice (Alzet osmotic pump; 25ng/kg; GD6 to PND18) [73] and Holtzman rats 
(oral gavage; 1.2 or 2.4µg/kg; GD12 to PND21) [54].  BPA also decreased the total number of pups born 
to gestationally and neonatally exposed CD1 mice (Alzet osmotic pump; 25µg/kg; GD6 to PND18) [73] 
and ICR mice (silicone tube; 5mg/tube; GD1 to PND21) [56].  Further, BPA decreased the total number of 
pups born to unexposed female Holtzman rats mated to gestationally and neonatally exposed male 
Holtzman rats (oral gavage; 1.2 or 2.4µg/kg; GD12 to PND21) [54] and neonatally exposed male 
Holtzman rats (s.c. injection; 400µg/kg; PND1-5) [41].   It is unclear from these studies why these 
findings are equivocal, thus, there is a need for more investigation into the birth outcomes of animal 
models.  Additionally, there is a need for human studies on whether BPA is associated with poor 
offspring delivery. 
 
The Effects of BPA on Birth Weight 
A cross-sectional study of 97 pregnant women showed that pregnant women with serum BPA 
concentrations greater than 2.51ng/mL had a higher risk for having low birth weight (LBW) male 
neonates that were small for gestational age (SGA), compared to women with lower serum BPA 
concentrations, though no association between LBW and SGA occurred in female neonates [75].  These 
results are consistent with a retrospective cohort study positively correlating maternal and paternal 
occupational exposure to BPA with LBW and SGA in 587 offspring [76].  Maternal exposure strengthened 
the correlation with LBW in offspring.  Additionally, in the occupationally exposed parents, there was a 
dose response relationship between increasing levels of BPA in air samples and decreased BW of the 
offspring [76].  In another cohort study of 40 pregnant women, urinary BPA levels at delivery were not 
associated with birth weights of the offspring, however, these results were not adjusted for lifestyle 
factors such as smoking or drinking, BMI, or age like the other studies, or compared with women with no 
or minimal detectable levels of BPA [77].    
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 In animal studies, the effects of BPA on birth weight of offspring are equivocal.  BPA increased 
the weight of offspring born to gestationally exposed ICR mice (s.c. injection; 200- 1000mg/kg; GD12-16) 
[78], and adult CD1 Swiss mice (dietary; 600mg BPA/kg; pre-breed to PND21) [48].  Conversely, BPA 
decreased the weight of offspring born to neonatally exposed pre-pubertal ICR mice (s.c. injection; BPA 
10 and 100mg/kg; PND8) [68].  However, BPA did not affect the weight of offspring born to gestationally 
and neonatally exposed C57BL/6J mice (dietary; 0, 0.33, 3.3, or 33 ppm; GD6 to PND21) [63].  Further, 
BPA did not affect the birth weight of offspring born to LE rats [(oral gavage; 2, 20, 200µg/kg; GD7 to 
PND18) or (oral gavage; 2.5 or 25µg/kg; GD21 to PND21)] [52;59], or SD rats (dietary; 0, 0.33, 3.3, or 33 
ppm; GD6 to PND21) [53].  It is unclear from these data why some, but not all studies show that BPA 
alter birth weight of offspring.  Strain differences may play a role in sensitivity to BPA, warranting further 
studies into the effects of species strain on BPA-induced alterations in the birth weight offspring.  
 
Conclusion 
 Collectively, the results summarized above indicate that BPA is a reproductive toxicant in 
humans, animal models, and in culture systems.  While many studies indicate that BPA negatively 
impacts the ovary, very few studies focused on the effects of BPA on the antral follicle.  Thus, the goal of 
my dissertation work was to determine if BPA negatively affects antral follicles and, if so, to determine 
the underlying mechanism of action.  
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CHAPTER III 
 
Bisphenol A inhibits follicle growth and steroidogenesis in cultured mouse antral follicles1 
 
3.1 Abstract  
Bisphenol A (BPA) is used as the backbone for plastics and epoxy resins, including various food 
and beverage containers.  BPA has also been detected in 95% of random urine samples and ovarian 
follicular fluid of adult women.  Few studies have investigated the effects of BPA on antral follicles, the 
main producers of sex steroid hormones and the only follicles capable of ovulation.  Thus, this study 
tested the hypothesis that postnatal BPA exposure inhibits antral follicle growth and steroidogenesis. To 
test this hypothesis, antral follicles isolated from 32-day-old FVB mice were cultured with vehicle control 
(dimethylsulfoxide; DMSO), BPA (1-100µg/mL), pregnenolone (10µg/mL), pregnenolone + BPA 10µg/mL, 
and pregnenolone + BPA 100µg/mL.  During the culture, follicles were measured for growth daily.  After 
the culture, media was subjected to enzyme-linked immunosorbent assays for hormones in the estradiol 
biosynthesis pathway, and follicles were processed for quantitative real-time polymerase chain reaction 
of steroidogenic enzymes.  The results indicate that BPA (100µg/mL) inhibits follicle growth and that 
pregnenolone co-treatment was unable to restore/maintain growth.  Further, BPA 10µg/mL and 
100µg/mL inhibit progesterone, dehydroepiandrosterone, androstenedione, estrone, testosterone, and 
estradiol production.  Pregnenolone co-treatment was able to increase production of pregnenolone, 
progesterone, and dehydroepiandrosterone and maintain androstenedione and estrone levels in BPA 
treated follicles compared to DMSO controls, but was unable to protect testosterone or estradiol levels.  
Further, pregnenolone was unable to protect follicles from BPA (10- 100µg/mL) induced inhibition of 
steroidogenic enzymes compared to the DMSO control. Collectively, these data show that BPA targets 
the estradiol biosynthesis pathway in the ovary. 
  
                                                             
1 Reprinted, with permission, from J. Peretz et al. Bisphenol A impairs follicle growth, steroidogenesis, and down-
regulates rate-limiting enzymes in the estradiol biosynthesis pathway. Toxicological Sciences 2011 Jan;119(1):209-
17. Epub 2010 Oct 18. 
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3.2 Introduction 
Bisphenol A (BPA), 2,2-bis-4-hydroxyphenyl propane, is an estrogenic compound originally 
synthesized in 1963 to prevent miscarriage.  BPA eventually became widely used as the backbone for 
epoxy resins, durable clear polycarbonate plastics such as reusable plastic food containers, food and 
beverage can liners, infant formula cans, baby bottles, and dental sealants, among many other plastic-
based products.  Unfortunately, aging, heating, and contact with acids and bases, including those 
commonly found in cleaning supplies and detergents, cause the BPA polymers to break apart.  In a 
process commonly referred to as “leaching,” BPA seeps into the contents of various food packages, into 
saliva, and/or into dust particles, providing ample entry ways for BPA into animal physiological systems, 
including humans (Lenie et al., 2008; Kang et al., 2006; Can et al., 2005; vom Saal and Hughes, 2005; 
Welshons et al., 2006; Vandenberg et al., 2007). 
 While BPA exposure can occur via food and drink (ingested), BPA can also be inhaled. Once in 
the lungs, BPA can travel through the bloodstream and into enterohepatic flow, where it can act as if 
ingested orally and travel through the digestive system.  Various studies have detected BPA in blood, 
saliva, and human tissues as well as in 95% of human urine samples taken in a random sampling (Calafat 
et al., 2005; Calafat et al., 2008).  Additionally, though BPA is thought to be conjugated to glucuronide in 
the digestive system and to exit the body via the urinary system, the chemical is not solely confined to 
the digestive system.  BPA has also been detected in mammary tissue, breast milk, amniotic fluid, and 
ovarian follicular fluid, indicating BPA travels not only through the digestive system, but also through the 
venous network, and thus into the many other organ and tissues systems of the body (Lenie et al., 2008; 
Vandenberg et al., 2009; Ikezuki et al., 2002; Vandenberg et al., 2007).   
 Recent research has suggested that BPA persists in the human system longer than originally 
thought.  In a study comparing BPA levels to fasting time, researchers found BPA persisting in the body 
well past the given 4-6h half-life of BPA.  Specifically, following 17h exposure, BPA levels only decreased 
56% instead of the expected 100% elimination.  This study suggests that BPA has a longer half-life than 
previously estimated; there are significant non-food source exposures of BPA, or, more likely, a 
combination of the two explanations (Tillet, 2009; Stahlhut et al., 2009).  Collectively, these findings 
suggest that humans are constantly exposed to BPA. 
 Studies focusing on the effects of BPA exposure on the rodent female reproductive system have 
shown that maternal exposure to BPA during gestation can cause adverse developmental effects in the 
offspring.  Specifically, BPA has been shown to induce early puberty onset, changes in weight gain, early 
vaginal opening (Honma et al., 2002), and ovarian morphological abnormalities in the offspring.  The 
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ovarian abnormalities include cystic ovaries (Hartshome, 1997) and cystadenomas, hemorrhagic follicles, 
and large, antral-like follicles seemingly unable to ovulate (Hartshome, 1997).  BPA also can cause 
progressive proliferative lesions of the oviduct (Savabiesasfahani et al., 2006), and leiomyomas in the 
uterus (Newbold et al., 2007).  Further, BPA increases estrogen receptor alpha (Esr1) and estrogen 
receptor beta (Esr2) receptor expression levels in the uterus (Richter, 2007).   
Few studies have investigated the direct effects of BPA on the ovarian follicle itself, the 
functional unit of the ovary and the main steroid hormone producer of the female reproductive system.  
Previous studies have focused mainly on meiotic abnormalities, such as cell cycle arrest, meiotic 
aneuploidy, and congression failure during the cell cycle (Eichenlaub-Ritter et al., 2008; Hunt et al., 
2003) or on morphological indicators of ovulation, such as observing a lack of corpora lutea in the ovary 
(Hartshome, 1997).  While BPA has been reported to be present in follicular fluid of adult human 
ovaries, previously published studies have not focused on antral follicles of adult humans and, as a 
result, little information is available regarding the effect of postnatal BPA exposure on the proper 
functioning of adult human ovarian follicles.  Further, little information is available on the effect of BPA 
on the proper functioning of ovarian antral follicles in the adult mouse model.  Thus, this study tested 
the hypothesis that postnatal exposure to BPA inhibits growth and steroidogenesis of adult ovarian 
antral follicles in mice. 
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3.3 Materials and Methods 
Chemicals:  BPA powder (99%) was purchased from Sigma-Aldrich (St. Louis, MO).  A stock solution of 
BPA was dissolved and diluted in dimethylsulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO) to achieve 
various BPA treatment concentrations (1.3, 13.3, 133 mg/mL) for final working concentrations of 1.0, 10, 
and 100 µg of BPA per mL of culture media.  Additionally, using these treatment concentrations allowed 
each working concentration to contain the same volume of chemical and vehicle (0.75µL BPA:DMSO per 
mL of culture media).   
The concentrations chosen for the cultures were based on concentrations used in previous 
studies (Lenie et al., 2008; Lee et al., 2007; Xu et al., 2006; Mlynarcikova et al., 2009; Can et al., 2005; 
Zhou et al., 2008; Watson et al., 2007; Vandenberg et al., 2007).  BPA concentrations were also chosen 
based on studies showing the effects of BPA on ovarian cells.  For example, BPA exposure between 100 
fM to 100 μM BPA for 24 to 72 hours results in an increase in apoptosis and G2-to-M arrest in cultured 
mouse ovarian granulosa cells (Xu et al., 2006). Our concentrations of BPA are relevant to current 
regulatory levels set for BPA.  The lowest observable adverse effect level (LOAEL) is 50/mg/kg/day.  This 
equates to 210.6µM.  The doses used in the experiments were 1, 10, or 100µg/mL (or 4.4, 44, and 
440µM), encompassing the LOAEL concentration.   
5-Pregnen-3β-ol-20-one (Pregnenolone; pregn) powder was purchased from Sigma-Aldrich (St. 
Louis, MO).  A stock solution of pregn was prepared in DMSO for a final concentration in culture of 
10µg/mL.   
 
Animals:  Adult, cycling, female FVB mice were purchased from Jackson Laboratory (Bar Harbor, Maine) 
and allowed to acclimate to the facility for at least five days before use. The mice were housed at the 
University of Illinois at Urbana-Champaign, Veterinary Medicine Animal Facility.  Food (Harlan Teklad 
8626) and water were provided for ad libitum consumption. Temperature was maintained at 22 ± 1 °C 
and animals were subjected to 12-hour light–dark cycles. The Institutional Animal Use and Care 
Committee at the University of Illinois at Urbana-Champaign approved all procedures involving animal 
care, euthanasia, and tissue collection.   
 
In vitro Follicle Culture:  Female FVB mice were euthanized on postnatal day (PND) 32 and their ovaries 
removed using aseptic technique. Antral follicles were mechanically isolated from the ovary based on 
relative size (250-400 µm), cleaned of interstitial tissue using fine watchmaker forceps (Gupta et al., 
2006; Miller et al., 2005), and individually placed in wells of a 96-well culture plate and covered with 
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unsupplemented α-minimal essential medium (α-MEM) prior to treatment. Sufficient numbers of antral 
follicles for statistical power were isolated from unprimed mouse ovaries; follicles from 2–3 mice were 
isolated per experiment providing approximately 20–40 antral follicles from each mouse.  Each 
experiment contained a minimum of 8–16 follicles per treatment group.  Doses of vehicle control 
(DMSO), BPA (1, 10, or 100µg/mL), pregn (10µg/mL), pregn + BPA (10µg/mL), and pregn + BPA 
(100µg/mL) were individually prepared in supplemented α-MEM.  Supplemented α-MEM was prepared 
with: 1% ITS (10 ng/ml insulin, 5.5 ng/ml transferrin, 5.5 ng/ml selenium), 100 U/ml penicillin, 100 
mg/ml streptomycin, 5 IU/ml human recombinant follicle-stimulating hormone (FSH; Dr. A. F. Parlow, 
National Hormone and Peptide Program, Harbor- UCLA Medical Center, Torrance, CA), and 5% fetal calf 
serum (Atlanta Biologicals, Lawrenceville, GA) (Miller et al., 2005; Gupta et al., 2006). An equal volume 
of chemical was added for each dose to control for the amount of vehicle in each preparation (0.75 
µL/mL of media: BPA treatments; 1.0 µL/mL of media: DMSO and pregn treatments).  Antral follicles 
were cultured for 120h in an incubator supplying 5% CO2 at 37°C. 
 
Analysis of Follicle Growth:  Follicle growth was examined at 24h intervals by measuring follicle 
diameter on perpendicular axes with an inverted microscope equipped with a calibrated ocular 
micrometer. Follicle diameter measurements were averaged among treatment groups and plotted to 
compare the effects of chemical treatments on growth over time. Data were presented as percent 
change over time. 
 
Analysis of Hormone Levels:  Media was collected after 120h of follicle culture and subjected to 
enzyme-linked immunosorbent assays (ELISA) for measurement of estradiol, estrone, testosterone, 
androstenedione, dehydroepiandrosterone-sulfate (DHEA-S) and progesterone levels. ELISA kits and 
reagents were obtained from ALPCO Diagnostics (estrone, testosterone, androstenedione, 
progesterone, DHEA-S) and Diagnostics Research Group (DRG) (estradiol). The assays were run using the 
manufacturer's instructions.  All samples were run in duplicate and all intra- and inter-assay coefficients 
of variability were less than 10%. 
 
Analysis of Quantitative Real-Time Polymerase Chain Reaction:  Female FVB mouse antral follicles were 
cultured as described above for 120h. At the end of culture, follicles were collected and snap frozen at – 
80°C for quantitative real-time polymerase chain reaction (qPCR) analysis. Total RNA was extracted from 
follicles using the RNeasy Micro Kit (Qiagen, Inc., Valencia, CA) according to the manufacturer's 
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protocol. Reverse transcriptase generation of cDNA was performed with 0.3–1 µg of total RNA using an 
iScript RT kit (Bio-Rad Laboratories, Inc.). qPCR was conducted using the CFX96 Real-Time PCR Detection 
System (Bio-Rad Laboratories, Inc.) and accompanying software (CFX Manager Software) according to 
the manufacturer's instructions. The CFX96 quantifies the amount of PCR product generated by 
measuring a dye (SYBR Green) that fluoresces when bound to double-stranded DNA. A standard curve 
was generated from five serial dilutions of one of the samples, thus allowing analysis of the amount of 
cDNA in the exponential phase. Specific qPCR primers for the genes of interest and annealing 
temperatures are listed in Table 3.1, along with GenBank accession numbers (Weihua et al., 2000; 
Pakarainen et al., 2005; Akingbemi et al., 2003; Sha et al., 1996; Hernandez et al., 2010). qPCR analysis 
was performed using 2 µl cDNA, forward and reverse primers (5 pmol) for steroidogenic acute 
regulatory protein (StAR), cytochrome P450 side chain cleavage (Cyp11a1), 3 β- hydroxysteroid 
dehydrogenase (3β-Hsd), 17β-hydroxysteroid dehydrogenase (17β-Hsd), cytochrome P450 aromatase 
(Cyp19), cytochrome P450 17 α-hydroxylase/17,20 lyase (Cyp17α), or β-actin, in conjunction with a 
SsoFast EvaGreen Supermix qPCR kit (Bio-Rad Laboratories, Hercules, CA). An initial incubation of 95°C 
for 10 min was followed by denaturing at 94°C for 10 s, annealing from 56-61°C for 10 s, and extension 
at 72°C for 10 s, for 40 cycles (β-actin), followed by final extension at 72°C for 10 min. A melting curve 
was generated at 55–90°C to monitor the generation of a single product. The software also generated a 
standard curve. β-Actin was used as reference gene for each sample. Final values were calculated and 
expressed as the ratio normalized to β-Actin. All analyses were performed in duplicate for at least 3 
separate experiments. 
 
Statistical Analysis: Data were expressed as means ± standard error of the means (SEM) and multiple 
comparisons between experimental groups were made using analysis of variance (ANOVA) followed by 
Tukey's post hoc comparison.  Tests for trend were analyzed using linear regression analyses for the 
overall effect of BPA concentration (continuous variable).  At least three separate experiments were 
conducted for each treatment prior to data analysis.  Statistical significance was assigned at p ≤ 0.05. 
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3.4 Results 
Effect of BPA on Follicle Growth:  Exposure to BPA (100µg/mL) significantly decreased antral follicle 
growth compared to DMSO controls beginning at 72h and this decrease in follicle growth remained 
throughout the 120h culture (Figure 1).  No significant differences in follicle growth were observed 
between follicles exposed to DMSO, BPA (10µg/mL), or BPA (1µg/mL).   
 
Effect of BPA on Sex Steroid Hormone Production:  BPA (100µg/mL) exposure for 120h significantly 
decreased estradiol, estrone, testosterone, androstenedione, DHEA-S, and progesterone levels 
produced by the follicles compared to DMSO (Figure 2).  BPA (10µg/mL) exposure for 120h significantly 
decreased estradiol, estrone, testosterone, androstenedione, DHEA-S, and progesterone levels 
produced by the follicles.  No significant differences in steroid levels were found between DMSO and 
BPA (1µg/mL). 
 
Effect of BPA on Gene Expression:  Since BPA decreased steroidogenesis in the cultured antral follicles, 
studies were conducted to see if it did so by decreasing the expression of enzymes required for 
steroidogenesis.  Specifically, levels of steroidogenic enzymes StAR, 3β-HSD, and Cyp17α were 
compared in control and BPA-treated follicles.  Only StAR mRNA expression levels were significantly 
decreased following exposure to BPA (10 and 100µg/mL) compared to DMSO controls (Figure 3 and 
Figure 6; BPA-only treated follicles).  Exposure to BPA (100µg/mL), however, resulted in a significant 
trend for decreased 3βHSD expression compared to controls. Further, BPA (10 and 100µg/mL) 
significantly decreased Cyp11a1 mRNA expression levels compared to DMSO controls (Figure 6; BPA-
only treated follicles). 
  
Effect of Pregnenolone Co-treatment on BPA-Treated Follicles:  The BPA-induced inhibition of 
steroidogenesis and follicle growth could be the result of decreased StAR and Cyp11a1 levels in the 
follicles because these are rate-limiting enzymes for the estradiol biosynthesis pathway.  Since addition 
of pregnenolone bypasses this disrupted enzyme, studies were conducted to investigate whether co-
treatment of follicles with pregnenolone and BPA would protect follicles from the toxic effects of BPA on 
follicle growth and steroidogenesis. 
Addition of pregnenolone to the supplemented media did not protect follicles from BPA-induced 
follicle growth inhibition (Figure 4). However, co-treatment of follicles with pregnenolone and BPA did 
provide some protection against inhibition of steroidogenesis (Figure 5).  Pregnenolone co-treatment 
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with BPA increased pregnenolone, progesterone, and DHEA-S levels compared to DMSO controls, and 
maintained androstenedione and estrone levels similar to DMSO controls.  Pregnenolone co-treatment 
with BPA, however, did not increase levels of testosterone and estradiol production compared to DMSO 
controls.  Specifically, progesterone levels were 2.94 ± 0.414 ng/mL with BPA (10µg/mL) only and 14.1 ± 
2.51 ng/mL with DMSO only, but progesterone levels were 5502.1 ± 387.2 ng/mL with pregn + BPA 
(10µg/mL). Androstenedione levels were 0.067 ± 0.003 ng/mL with BPA (10µg/mL) only and 1.10 ± 0.203 
ng/mL with DMSO only, but androstenedione levels were 1.03 ± 0.04 ng/mL with pregn + BPA 
(10µg/mL). Estradiol levels were 378.1 ± 54.5 pg/mL with BPA (10µg/mL) only, 5417.8 ± 1849.9 pg/mL 
with DMSO only, and 465.6 ± 11.2 pg/mL with pregn + BPA (10µg/mL). 
 
Effect of Pregnenolone + BPA on Gene Expression:  Since levels of pregnenolone, DHEA-S, 
progesterone, androstenedione, and estrone were protected from BPA-induced inhibition in the 
pregnenolone treated groups compared to their non-pregnenolone counterparts, gene expression levels 
of the enzymes responsible for their metabolism along the biosynthesis pathway were measured.  
Addition of pregnenolone treatment did not protect the follicles from BPA-induced alterations in 
steroidogenic enzyme gene expression (Figure 6). Specifically, StAR mRNA expression levels were 0.086 
± 0.037 genomic equivalents (ge) with BPA (10µg/mL) only and 0.409 ± 0.038 ge with DMSO, but StAR 
mRNA expression levels were 0.090 ± 0.006 ge with pregn + BPA (10µg/mL).  Cyp11a1 mRNA expression 
levels were 0.076 ± 0.010 ge with BPA (10µg/mL) only and 0.374 ± 0.069 ge with DMSO only, but 
Cyp11a1 mRNA expression levels were 0.026 ± 0.13 ge with pregn + BPA (10µg/mL). 
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3.5 Discussion 
Using the in vitro follicle culture system, we have shown that BPA inhibits follicle growth and 
decreases hormone production in mouse ovarian antral follicles. Further, while co-treatment with 
pregnenolone did not protect follicles from BPA-induced inhibition of follicle growth, it partially 
protected follicles from BPA-induced inhibition of steroidogenesis.   
Sex steroid hormone production is required for proper development of antral follicles (Cain et 
al., 1995).  These hormones produced in the ovary have an autocrine effect on the growth and 
development of follicles.   Estrogens, such as estradiol, stimulate follicle growth and protect the follicle 
from atresia (Quirk, 2007).  Progestins, such as progesterone, have an inhibitory effect and induce 
atresia, though the specific actions of progesterone on the follicle are not currently understood (Fukuda 
et al., 1980). Androgens, such as androstenedione, testosterone, and dehydrotestosterone, have been 
reported to both stimulate follicle growth and induce atresia in antral follicles (Drummond, 2006).  
Hormone production is dependent on the components of the estradiol biosynthesis pathway. More 
specifically, production of downstream hormones in the pathway, such as estradiol, is dependent on the 
availability of upstream hormones, such as progestins and androgens.  All the hormones within the 
biosynthesis pathway are dependent on the availability of the lipid precursor, cholesterol.  Furthermore, 
the rate-limiting step of the estradiol biosynthesis pathway is the transport of cholesterol by StAR from 
lipid droplets in the theca cells into the inner matrix of the mitochondria.  Therefore, without this 
transport, cholesterol cannot be converted to pregnenolone via Cyp11a1 and further hormone 
metabolism and production in the antral follicles is inhibited.  Our results suggest that both StAR and 
Cyp11a1 mRNA expression are inhibited following exposure to BPA.  This would prevent cholesterol 
uptake into the mitochondria and metabolism to pregnenolone, explaining the decrease in hormone 
production following exposure to BPA in our study.  
To try and bypass these enzymes, we added pregnenolone to the culture.  We hypothesized that 
the pregnenolone addition would protect the follicles from inhibited growth and hormone production.  
Exposing the follicles concurrently to pregnenolone and BPA did not prevent inhibition of follicle growth, 
but protected hormone production in the theca cells, though not necessarily in the granulosa cells.  
These data support our finding that StAR and Cyp11a1 mRNA levels are inhibited by BPA.  Thus, 
cholesterol uptake into the mitochondria and metabolism to pregnenolone is inhibited, impairing 
hormone production in the antral follicles. Without adequate hormone levels, late antral follicle growth 
and ovulation will be impaired, as well as further hormone production within the follicles, thus affecting 
fertility. 
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  Our results support previous work indicating that BPA exposure affects progesterone production 
using porcine granulosa cells incubated for 24-72 hr, though this previous work was done in isolated 
granulosa cells, not the whole follicle as in our study (Mlynarcikova et al., 2005). Another study using 
isolated granulosa and theca-interstitial cells investigated hormone production from gonadotropin-
primed follicular cells. This study found exposure to BPA between 10-7 and 10-5M increased StAR, 
Cyp11a1, and 3β-Hsd mRNA expression and protein levels and increased testosterone and progesterone 
production, but it decreased estradiol levels and Cyp19 mRNA expression levels (Zhou et al., 2008).  Our 
results suggest the opposite, indicating BPA exposure decreases StAR and Cyp11a1 mRNA levels and 
decreases testosterone and progesterone production.  The reasons for the different results from our 
study and the previous study could stem from species differences.  We used mice, while the other study 
used rats.  Further, differences in results could stem from the fact that we used isolated, intact whole 
follicles, the functional unit of the ovary, where the previous study used isolated granulosa and theca-
interstitial cells.     
Our data indicate that BPA affects steroidogenesis in the granulosa and theca cells, beginning by 
down-regulating StAR and later, affecting granulosa-theca cell communication including hormone 
diffusion from the theca into the granulosa cells.  This could be why pregnenolone co-treatment 
restores hormone levels in the theca to at least DMSO control levels following exposure to BPA, but why 
hormones levels in the granulosa cells, such as testosterone and estradiol, are still decreased compared 
to DMSO controls. Malfunctioning granulosa cells could lead to impaired follicle growth in antral follicles 
because the proliferation of these cells is responsible for the increasing size of the developing follicles.  
Further, hormone production could be impaired because the granulosa cells are the only cells in the 
antral follicle able to aromatize androgens produced in the theca into estrogens (Drummond, 2006).  
 In conclusion, this study shows that the estradiol biosynthetic pathway in the ovary is a possible 
target for BPA action in the mouse.  Impaired steroid biosynthesis could affect functioning of the 
endocrine system throughout the body, meriting further research in animal models. Further, as the 
mouse endocrine system is similar to the human in many regards, further research in human models is 
also warranted. 
  
47 
 
 
3.6 Tables, Figures, and Legends 
 
Table 3.1 Specific primer sequences for qPCR 
 
 
 
Specific sequences for primers used in qPCR.   
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Figure 3.1 Effect of BPA exposure of FVB mice antral follicle growth.   
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Antral follicles were mechanically isolated from FVB mice and exposed in vitro to BPA (1-100µg/mL) for 
120h.  Growth of follicles was monitored during culture and recorded in micrometers and reported as 
percent change over time.  The graph represents means ± SEMs from at least three separate 
experiments.  Line with asterisk (*) is significantly different from controls (n= 8-16 follicles per treatment 
per experiment from at least three separate experiments; p≤0.05). 
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Figure 3.2 Effect of BPA exposure on antral follicle hormone production 
  
 
 
 
After exposure of antral follicles to DMSO control or BPA (1-100µg/mL) for 120h in vitro, media was 
collected and subjected to various hormone measurements by enzyme-linked immunosorbent assay. 
These graphs represent the means ± SEMs from separate experiments. A single asterisk (*) denotes a 
significant p-value for overall effect of BPA concentration as the continuous variable using linear 
regression.  A double asterisk (**) denotes a significant p-value from the DMSO control via ANOVA, post-
hoc Tukey’s HSD (n=3-4; p≤ 0.05). 
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Figure 3.3 Effect of BPA exposure on StAR, 3β-Hsd, and Cyp17α mRNA expression levels.  
 
 
 
 
 
 
 
 
 
After exposure of antral follicles to DMSO control of BPA (1-100µg/mL) for 120h in vitro, the follicles 
were collected and subjected to qPCR analysis for StAR, 3β-Hsd, and Cyp17α  mRNA expression levels.  
All values were normalized to β-actin as a loading control.  Graph represents means ± SEMs from 
separate experiments.  A single asterisk (*) denotes a significant p-value for overall effect of BPA 
concentration as the continuous variable using linear regression.  A double asterisk (**) denotes a 
significant p-value from the DMSO control via ANOVA, post-hoc Tukey’s HSD (n=8-16 follicles per 
treatment per experiment from 3 separate experiments; p≤ 0.05). 
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Figure 3.4 Effect of pregnenolone co-treatment with BPA on antral follicle growth 
  
 
 
Antral follicles were mechanically isolated from FVB mice and exposed in vitro to BPA (1-100µg/mL), 
pregnenolone (10µg/mL) or pregnenolone and BPA (10-100µg/mL) for 120h.  Growth of follicles was 
monitored during culture and recorded in micrometers and reported as percent change.  The graph 
represents means ± SEMs from at least three separate experiments.  Lines with asterisks (*) are 
significantly different from DMSO controls (n= 8-16 follicles per treatment per experiment from at least 
three separate experiments; p≤0.05). 
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Figure 3.5 Effect of pregnenolone co-treatment with BPA on antral follicle hormone production 
  
 
 
After exposure of antral follicles to DMSO control, BPA (1-100µg/mL) pregnenolone (10µg/mL) or 
pregnenolone and BPA (10-100µg/mL) for 120h in vitro, media was collected and subjected to various 
hormone measurements by enzyme-linked immunosorbent assay. These graphs represent the means ± 
SEMs from separate experiments.  Asterisks (*) indicate a significant difference between no 
pregnenolone and pregnenolone groups; symbols (†) indicate a significant difference between BPA and 
control groups without pregnenolone; letters indicate a significant difference between BPA and control 
groups with pregnenolone groups (n=3-4; p≤ 0.05). 
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Figure 3.6 Effect of pregnenolone co-treatment with BPA on steroidogenic enzyme mRNA expression 
levels.   
  
 
 
After exposure of antral follicles to DMSO control, BPA (1-100µg/mL) pregnenolone (10µg/mL) or 
pregnenolone and BPA (10-100µg/mL) for 120h in vitro, the follicles were collected and subjected to 
qPCR analysis for StAR, Cyp11a1, 3β-Hsd, Cyp19, and 17β-Hsd mRNA expression levels.  All values were 
normalized to β-actin as a loading control.  Graph represents means ± SEMs from separate experiments.  
Asterisks (*) indicate a significant difference between no pregnenolone and pregnenolone groups; 
symbols (†) indicate a significant difference between BPA and control groups without pregnenolone; 
letters indicate a significant difference between BPA and control groups with pregnenolone groups (n=3-
4; p≤ 0.05). 
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CHAPTER IV 
 
Bisphenol A alters cell cycle regulators and induces atresia in culture mouse antral follicles 
independently of the genomic estrogenic pathway, inhibiting follicle growth2 
 
4.1 Abstract 
Bisphenol A (BPA) is an estrogenic chemical used to manufacture many commonly used plastic 
and epoxy resin-based products.  BPA ubiquitously binds to estrogen receptors throughout the body, 
including estrogen receptor alpha (ESR1) in the ovary.  Few studies have investigated the effects of BPA 
on ovarian antral follicles.  Thus, we tested the hypothesis that BPA alters cell cycle regulators and 
induces atresia in antral follicles via the genomic estrogenic pathway, inhibiting follicle growth.  To test 
this hypothesis, antral follicles were isolated from 32-35 day-old control and Esr1 over-expressing mice 
and cultured with vehicle control (dimethylsulfoxide; DMSO) or BPA (1-100µg/mL).   Additionally, antral 
follicles were isolated from 32-35 day-old FVB mice and cultured with DMSO, BPA (1-100µg/mL), 
estradiol (10nM), ICI 182,780 (ICI; 1µM), BPA+ICI, or BPA+estradiol.  Every 24 hours (hrs) for 96-120hrs, 
follicles were measured for growth and processed either for analysis of estrogen receptor, cell cycle, 
and/or atresia factor mRNA expression, or for histological evaluation of atresia.  The results indicate that 
estradiol and ICI do not protect follicles from BPA-induced growth inhibition and estradiol does not 
protect follicles from BPA-induced atresia.  Further, over-expressing Esr1 does not increase susceptibility 
of follicles to BPA-induced growth inhibition.  Additionally, BPA up-regulates Cdk4, Ccne1, and Trp53 
expression, while down-regulating Ccnd2 expression.  BPA also up-regulates Bax and Bcl2 expression, 
while inducing atresia in antral follicles.  These data indicate that BPA abnormally regulates cell cycle 
and atresia factors, and this may lead to atresia and inhibited follicle growth, independently of the 
genomic estrogenic pathway.
                                                             
2 Reprinted, with permission, from J. Peretz et al. Bisphenol A Inhibits Follicle Growth and Induces Atresia in 
Cultured Mouse Antral Follicles Independently of the Genomic Estrogenic Pathway. Biology of Reproduction 2012 
Sep;87(3):63: 1-11. 
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4.2 Introduction 
Bisphenol A (BPA) is a synthetic estrogen used in the manufacturing of commonly used 
consumer products such as polycarbonate plastics and epoxy resins of food and beverage cans.  Human 
exposure levels of BPA have been reported in various tissues, including, but not limited to, adult sera 
(0.2- 20ng/mL), fetal sera (averaging 8.3ng/mL), placental tissues (11.2ng/g), human breast milk (0.28–
0.97ng/mL), human colostrum (1–7ng/mL), and urine (1.12ng/ml; women) [1].  BPA exposure has also 
been measured in Chinese men (sera: 2.84μg/mL; median personal airborne level: 450 μg/mL) working 
in factories producing BPA and products containing BPA, such as epoxy resins [2;3].  Further, the 
estimated daily intake of BPA is thought to range from 0.6–71.4μg/day based on urine samples taken in 
the morning from human study subjects [1;4].  In a government funded study (NHANES III), BPA has 
been found to be present in 95% of human urine samples, indicating that humans are constantly 
exposed to measurable levels of BPA [5]. 
BPA is an endocrine disrupting chemical and can interact with various endocrine receptors in the 
female reproductive tract, including estrogen receptors alpha (ESR1) and beta (ESR2) [6;7].  BPA has also 
been shown to interact with the membrane bound estrogen receptor (GPR30) in human breast cancer 
cells [8] as well as estrogen-related receptor gamma in competitive receptor-binding assays [9], 
indicating that BPA may work through genomic and non-genomic estrogen related pathways.  Previous 
studies indicate that BPA can affect facets of the reproductive and endocrine system, including behavior 
[10;11], sexual development in the brain [12;13], and prostate tumor cell proliferation [14].  Also, in the 
ovary, BPA exposure impairs early oogenesis, induces meiotic incompetence, arrest, and aneuploidy, 
increases chromosomal congression failure during meiosis, and alters Ca2+ oscillations within oocyte 
isolated from antral follicles [15-18].  However, while these studies investigated the effects of BPA on 
oocytes isolated from antral follicles, few studies have focused on the effects of BPA on whole antral 
follicles.  Further, it is not known if BPA works through Esr pathways in antral follicles. Thus, a goal of 
this study was to test the hypothesis that BPA inhibits antral follicle growth through Esr pathways. 
Follicles are the functional units of the ovary, which are responsible for growing and housing the 
oocyte and for producing sex steroid hormones.   Follicles grow and develop from the primordial stage 
to the antral and pre-ovulatory stages throughout the reproductive life of a female [19].  Each stage of 
follicle development is accompanied by an increase in the number of cell layers present in the follicle.  
For example, primordial and primary follicles have a single layer of granulosa cells surrounding the 
oocyte.  Pre-antral, antral, and pre-ovulatory follicles all have multiple layers of granulosa cells and outer 
cell layers called the thecal layers.  Follicle growth is required for the follicle to ovulate and release the 
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oocyte for fertilization.  Any perturbations in follicle growth can lead to improper oocyte development, 
anovulation, and abnormal sex steroid hormone levels.  In turn, this can result in subfertility or infertility 
[20;21].  Without proper growth, the follicle will also be marked for programmed cell death and undergo 
atresia, preventing ovulation [20;21].  Over 99% of the finite follicles in the follicular pool at birth will 
undergo atresia, leaving 1% to properly develop and ovulate for fertilization during the reproductive 
lifespan [22;23].  Exposure to reproductive toxicants that decrease the proper development of antral 
follicles can hinder normal reproduction.  
BPA has been shown to inhibit mouse antral follicle growth in vitro [24].  Follicle growth is 
dependent on the proliferation of granulosa and thecal cells [25].  Like most other cells in the body, 
granulosa and thecal cell proliferation is dependent upon the cell cycle [Figure 4.1] [26].  The cell cycle is 
controlled in a directional and sequential pattern by cell cycle regulators, complexes of proteins called 
cyclins and cyclin-dependent kinases (CDK) [26;27].  These cyclin:CDK complexes are responsible for 
promoting cell survival by protecting the cell from replicating with damaged DNA or from mutations that 
may lead to aberrant and uncontrolled cell growth [20]. Cyclin D2 (CCND2) and cyclin-dependent kinase 
4 (CDK4) form a complex that monitors the progression of a cell through early G1 phase.  This complex 
directly up-regulates cyclin E1 (CCNE1), a cell cycle regulator part of another cyclin:CDK complex that 
monitors the progression of a cell at the end of G1 phase and prevents entry into S phase if necessary 
[20].  Each cyclin:CDK complex in the cell cycle acts as a checkpoint and can, if necessary, halt the cells 
progression through the cell cycle and either arrest  progression or program cells for death.  
Transformation related protein, TRP53, is a specific factor that controls whether the cyclin:CDK 
complexes allow cells to progress through the cycle [20].  TRP53, after induction by tissue damage or 
release from binding inactivation, can down-regulate and inactivate the cyclin:CDK complex, arresting 
cell growth or inducing cell death [20;27].  Given that BPA inhibits antral follicle growth [24] and antral 
follicle growth is partially controlled by cell cycle regulators [27], a second goal of this study was to test 
the hypothesis that BPA alters expression of cell cycle regulators in antral follicles, possibly leading to 
inhibition in growth. 
In addition to inhibiting follicle growth by reducing expression of cell cycle regulators, it is 
possible that BPA inhibits follicle growth by inducing atresia.  Atresia, or programmed cell death of 
antral follicles, is complimentary to the cell cycle and follicle growth (Figure 4.1) [27].  Thus, a third goal 
of this study was to test the hypothesis that BPA induces atresia of antral follicles. 
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4.3 Materials and Methods 
Chemicals:  BPA powder (99%) was purchased from Sigma-Aldrich (St. Louis, MO).  A stock solution of 
BPA was dissolved and diluted in dimethylsulfoxide (DMSO) (Sigma-Aldrich, St. Louis, MO) to achieve 
various BPA treatment concentrations (1.3, 13.3, 133 mg/mL) for final working concentrations of 1, 10, 
and 100 µg of BPA per mL of culture media.  Using these treatment concentrations allowed each 
working concentration to contain the same volume of chemical and vehicle.   
BPA concentrations were also chosen based on studies showing the effects of BPA on ovarian 
cells and antral follicles [24;28].  For example, BPA exposure between 100fM to 100μM BPA for 24 to 
72hrs results in an increase in apoptosis and G2-to-M arrest in cultured mouse ovarian granulosa cells 
[28].  Additionally, BPA exposure between 10 and 100μg/mL for 120hrs results in a decrease in antral 
follicle growth, steroidogenesis, and expression of steroidogenic enzymes in vitro [24]. Our 
concentrations of BPA are relevant to current regulatory levels set for BPA.  The lowest observable 
adverse effect level (LOAEL) is 50 mg/kg/day.  This equates to 50 µg/mL.  The doses used in the 
experiments were 1, 10, and 100µg/mL, encompassing the LOAEL concentration.   
 Estradiol was obtained from Sigma Aldrich (St. Louis, MO). A stock solution of estradiol was 
dissolved and diluted in DMSO (20μM) for a final concentration in culture of 10nM.  ICI 182,780 (ICI), a 
high-affinity ESR antagonist, was obtained from Tocris-Cookson (Ellisville, MO). Stock solutions of ICI 
were dissolved in DMSO (2mM) for a final concentration in culture of 1μM.  The final concentrations of 
estradiol and ICI in culture were chosen based on previous studies in our lab [29]. 
 
Animals:  Adult, cycling, female FVB (sensitivity to Friend leukemia virus B strain) mice were purchased 
from Jackson Laboratory (Bar Harbor, Maine) and allowed to acclimate to the facility for at least five 
days before use.  Esr1 overexpressing (Esr1 OE) and control mice used in this study were generated as 
previously described and obtained from a breeding colony at the University of Illinois [30;31].  Esr1 OE 
mice were validated for the overexpression of Esr1 gene and protein levels in the ovaries and antral 
follicles compared to control mice as previously described [30].  All mice were housed at the University 
of Illinois at Urbana-Champaign, Veterinary Medicine Animal Facility.  Food (Harlan Teklad 8626) and 
water were provided for ad libitum consumption. Temperature was maintained at 22 ± 1 °C and animals 
were subjected to 12-hour light–dark cycles. The Institutional Animal Use and Care Committee at the 
University of Illinois at Urbana-Champaign approved all procedures involving animal care, euthanasia, 
and tissue collection.   
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Follicle Culture:  Female FVB mice were euthanized on postnatal day (PND) 32-35 and their ovaries 
removed using aseptic technique. Antral follicles were mechanically isolated from the ovary based on 
relative size (250-400 µm), cleaned of interstitial tissue using fine watchmaker forceps [23;32], and 
individually placed in wells of 96-well culture plates containing unsupplemented α-minimal essential 
media (α-MEM) prior to treatment. Sufficient numbers of antral follicles for statistical power were 
isolated from unprimed mouse ovaries; follicles from 2–3 mice were isolated per experiment providing 
approximately 20–40 antral follicles from each mouse.  Each experiment contained a minimum of 8–16 
follicles per treatment group.  Concentrations of vehicle control (DMSO), BPA (1-100µg/mL), estradiol 
(10nM), and ICI (1μM) were individually prepared in supplemented α-MEM.  Supplemented α-MEM was 
prepared with: 1% ITS (10ng/ml insulin, 5.5ng/ml transferrin, 5.5ng/ml selenium), 100 U/ml penicillin, 
100mg/ml streptomycin, 5 IU/ml human recombinant follicle-stimulating hormone (FSH; Dr. A. F. 
Parlow, National Hormone and Peptide Program, Harbor- UCLA Medical Center, Torrance, CA), and 5% 
fetal calf serum (Atlanta Biologicals, Lawrenceville, GA) [23;32]. An equal volume of chemical was added 
for each treatment to control for the amount of vehicle in each preparation.  In some cultures, antral 
follicles were co-treated with BPA+ estradiol treatments.  In follicle cultures with ICI, antral follicles were 
pre-treated with ICI in supplemented alpha-MEM for two hours prior to subsequent BPA, ICI, and 
BPA+ICI treatments.  All antral follicles were cultured for 24-120hrs in an incubator supplying 5% CO2 at 
37°C. 
Follicle growth was measured at 24hr intervals beginning at 0hr by measuring follicle diameter 
on a perpendicular axis with an inverted microscope equipped with a calibrated ocular micrometer.  
Follicle measurements were averaged among treatment groups at each time-point and data were 
presented as percent change in growth over time per treatment group.  Images of the follicles were 
taken using the digital microscope camera ProgRes CT3 (Jenoptik, Germany) and captured using ProgRes 
CapturePro (Jenoptik, Germany) image acquisition software. 
 
Analysis of Atresia:  At the end of follicle culture (48 or 120hrs), supplemented α-MEM was removed 
from each well and Dietrick's solution was added to fix the follicles. Follicles were fixed for at least 24hrs 
in Dietrick's solution and transferred in histology cassettes to 70% ethanol. The tissues were dehydrated, 
embedded using Technovit kits from Heraeus Kulzer GmbH, Germany, serially sectioned (2μm), 
mounted on glass slides, and stained with Lee’s methylene blue-basic fuchsin stain. Each follicle section 
was examined for the level of atresia as evidenced by the presence of apoptotic bodies and reported at 
the highest level observed throughout the follicle. Follicle sections were rated on a scale of 1–4 for the 
62 
 
 
presence of apoptotic bodies: 1 = 0 apoptotic bodies (healthy), 2 = < 10% apoptotic bodies (early 
atresia), 3 = 10–30% apoptotic bodies (mid atresia), and 4 = > 30% apoptotic bodies (late atresia), as 
previously described [32]. All analyses were conducted without knowledge of treatment group. Ratings 
were averaged and plotted to compare the effect of BPA treatments on atresia levels.  Images of the 
follicles were taken at 40x magnification using the digital microscope camera Leica DFC290 and captured 
using ImagePro image acquisition software (Leica Microsystems, Switzerland). 
 
Analysis of Gene Expression:  Female FVB mouse antral follicles were cultured as described above for 
24-96hrs. At the end of culture, follicles were collected and snap frozen at – 80°C for quantitative real-
time polymerase chain reaction (qPCR) analysis. Total RNA was extracted from follicles using the RNeasy 
Micro Kit (Qiagen, Inc., Valencia, CA) according to the manufacturer's protocol. Reverse transcriptase 
generation of cDNA was performed with 0.3–1 µg of total RNA using an iScript RT kit (Bio-Rad 
Laboratories, Inc.). qPCR was conducted using the CFX96 Real-Time PCR Detection System (Bio-Rad 
Laboratories, Inc.) and accompanying software (CFX Manager Software) according to the manufacturer's 
instructions. The CFX96 quantifies the amount of PCR product generated by measuring a dye (SYBR 
Green) that fluoresces when bound to double-stranded DNA. A standard curve was generated from five 
serial dilutions of one of the samples, thus allowing analysis of the amount of cDNA in the exponential 
phase. qPCR analysis was performed using 2 µl cDNA, forward and reverse primers (5pmol) for estrogen 
receptor alpha (Esr1; NM_007956), estrogen receptor beta (Esr2; NM_207707), cyclin-dependent kinase 
4 (Cdk4; NM_009870.3), cyclin D2 (Ccnd2; NM_009829.3), cyclin E1 (Ccne1; NM_007633.2), 
transformation related protein 53 (Trp53; NM_011640.3), B-cell lymphoma 2 (Bcl2; NM_009741.3), Bcl2-
associated X protein (Bax; NM_007527.3), or beta-actin (Actb; NM_007393), in conjunction with a 
SsoFast EvaGreen Supermix qPCR kit (Bio-Rad Laboratories, Hercules, CA). An initial incubation of 95°C 
for 10 min was followed by denaturing at 94°C for 10 s, annealing from 60°C for 10 s, and extension at 
72°C for 10 s, for 40 cycles (β-actin), followed by final extension at 72°C for 10 min. A melting curve was 
generated at 55–90°C to monitor the generation of a single product. The software also generated a 
standard curve.  Actb was used as reference gene for each sample. Final values were calculated and 
expressed as the ratio normalized to Actb. All analyses were performed in duplicate for at least 3 
separate experiments.   
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Statistical Analysis:  Data were expressed as means ± standard error of the means (SEM) and multiple 
comparisons between experimental groups were made using general linearized model (GLM), analysis of 
variance (ANOVA) as applicable, followed by Tukey's Post hoc comparisons.  At least three separate 
experiments were conducted for each treatment prior to data analysis.  Statistical significance was 
assigned at p ≤ 0.05. 
  
64 
 
 
4.4 Results 
Effect of BPA Treatment on Follicle Growth:  Previous studies indicate that BPA inhibits follicle growth 
in mouse antral follicles [24]. In these current studies, we expanded previous work by testing the 
hypothesis that BPA inhibits follicle growth through ESR pathways.  Thus, it was first important to 
determine if BPA inhibits follicle growth in the current studies similarly to previous studies.  Exposure to 
BPA (100µg/mL) significantly decreased follicle growth compared to DMSO beginning at 72hrs and 
continuing throughout culture [Figure 4.2].  BPA (1µg/mL) and BPA (10µg/mL) did not significantly affect 
growth compared to DMSO at any time point. 
Morphological changes in follicle growth were consistent with data indicating follicle growth is 
significantly inhibited after exposure to BPA (100µg/mL) compared to DMSO beginning at 72hrs and 
continuing throughout culture [Figure 4.2].  In DMSO treated follicles, follicle size steadily increased over 
time, suggesting that cells were proliferating, resulting in a “fuzzy” appearance [Figure 4.3; Panel A].  In 
BPA (100µg/mL) treated follicles, size did not significantly change over time, suggesting no significant 
proliferation within the follicle [Figure 4.3; Panel B]. 
 
Effects of BPA Treatment on Esr Pathways in Antral Follicles:  To begin to examine whether BPA utilizes 
ESR pathways in antral follicles, we first examined the effect of BPA on expression of Esr1 and Esr2 in 
antral follicles.  Exposure to BPA (1µg/mL) decreased Esr1 expression at 24hrs compared to DMSO, but 
returned to control levels at 48, 72, and 96hrs.  Exposure to BPA (100µg/mL) significantly increased Esr1 
expression at 24hrs, but decreased Esr1 expression at 72hrs compared to DMSO controls [Figure 4.4; 
Panel A].  BPA (10µg/mL) did not alter Esr1 expression at any time point. Exposure to BPA (10µg/mL) 
significantly increased Esr2 expression compared to DMSO controls beginning at 24hrs and continuing 
through 72hrs of culture [Figure 4.4; Panel B].  BPA (1µg/mL) and BPA (100µg/mL) did not significantly 
alter expression of Esr2 at any time point.   
To determine if BPA works through the ESR pathway, we next co-treated antral follicles with 
BPA and estradiol to examine if estradiol could block BPA-induced growth inhibition.  Exposure to BPA 
(100µg/mL) significantly decreased follicle growth compared to DMSO and estradiol controls [Figure 4.5; 
Panel A].  Estradiol co-treatment did not protect antral follicles from BPA-induced inhibition of follicle 
growth [Figure 4.5; Panel A].  
Further, to determine if blocking ESRs in antral follicles could protect antral follicles from BPA-
induced follicle growth inhibition, we pre-treated antral follicles with the ESR antagonist, ICI, to examine 
if ICI blocks BPA-induced growth inhibition.  Exposure to BPA (100µg/mL) significantly decreased follicle 
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growth compared to DMSO and ICI controls [Figure 4.5; Panel B].  Pre-treating the follicles with ICI did 
not protect antral follicles from BPA-induced inhibition of follicle growth [Figure 4.5; Panel B].   
Finally, because previous studies have shown that overexpressing ESR1 increases the 
susceptibility of follicles to growth inhibition induced by other estrogenic endocrine disrupting chemicals 
[30],  we treated Esr1 OE mouse antral follicles with BPA to determine if overexpressing Esr1 increases 
the susceptibility of follicles to BPA-induced growth inhibition. Exposure to BPA (100µg/mL) significantly 
decreased follicle growth compared to DMSO in control [Figure 4.6; Panel A] and Esr1 OE [Figure 4.6; 
Panel B] follicles beginning at 72hrs and continuing throughout culture.  BPA (1µg/mL) and BPA 
(10µg/mL) did not significantly affect growth in either control or Esr1 OE follicles.  
 
Effect of BPA on Cell Cycle Regulators:  Even though BPA does not work through ESR1 to inhibit follicle 
growth, BPA still inhibits follicle growth [Figure 4.2].  Thus, we next examined if BPA alters the 
expression of cell cycle regulators in antral follicles because cell cycle regulators have been shown to 
control granulosa cell proliferation and, thus, control follicle growth [26].  Exposure to BPA (100µg/mL) 
significantly increased Cdk4 expression compared to DMSO controls beginning at 24hrs and continuing 
throughout culture [Figure 4.7; Panel A].  BPA (1µg/mL) and BPA (10µg/mL) did not significantly affect 
Cdk4 expression compared to DMSO at any time point.  Exposure to BPA (100µg/mL) significantly 
decreased Ccnd2 expression compared to DMSO at 48hrs [Figure 4.7; Panel B].  BPA (1µg/mL) and BPA 
(10µg/mL) did not significantly affect Ccnd2 expression compared to DMSO at any time point.  Exposure 
to BPA (100µg/mL) significantly increased Ccne1 expression compared to DMSO beginning at 24hrs and 
continuing throughout culture [Figure 4.8; Panel A].  BPA (1µg/mL) and BPA (10µg/mL) did not 
significantly affect Ccne1 expression compared to DMSO at any time point.  Exposure to BPA (100µg/mL) 
significantly increased Trp53 expression compared to DMSO beginning at 24hrs and continuing 
throughout culture [Figure 4.8; Panel B].  BPA (1µg/mL) and BPA (10µg/mL) did not significantly affect 
Trp53 expression compared to DMSO at any time point. 
 
Effect of BPA on Atresia of Antral Follicles:  Another mechanism by which BPA may inhibit follicle 
growth may include inducing atresia.  If BPA induces atresia, the follicles would not be able to grow 
normally.  Thus, we conducted studies to determine if BPA induces atresia.  Atresia was rated by 
quantifying the percentage of apoptotic bodies present in the follicles.  These morphological changes in 
the follicle were used to determine that BPA (100µg/mL) induces atresia compared to DMSO beginning 
at 48hrs and continuing at 120hrs in culture [Figure 4.9; Panel A-D].  They also were used to determine 
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that estradiol co-treatment does not protect the follicles from BPA-induced atresia [Figure 4.9; Panel E, 
F].  In DMSO and estradiol treated follicles at 48hrs and 120hrs, granulosa cells were tightly organized 
together in layers and no apoptotic bodies are present within the follicle [Figure 4.9; Panel A, C, E].  In 
BPA (100µg/mL) and BPA (100µg/mL)+estradiol (10nM) treated follicles, beginning at 48hrs and 
continuing at 120hrs, granulosa cells were no longer tightly organized into multiple layers and apoptotic 
bodies were present (indicated by red arrows) in greater than 30% of the follicle.  Further, after 
exposure to BPA (100µg/mL) or BPA (100µg/mL)+estradiol (10nM) at 120hrs, few granulosa cells 
remained in the follicle [Figure 4.9; Panel B, D, F].  Exposure to BPA (100µg/mL) significantly induced 
atresia at 48 and 120hrs compared to DMSO [Figure 4.10; Panel A].  Co-treatment with estradiol did not 
protect antral follicles from BPA-induced atresia [Figure 4.10; Panel B] at any time point.   
Because BPA induces atresia in antral follicles [Figure 4.10], we next determined if BPA alters the 
expression of selected regulators of atresia.  Exposure to BPA (100µg/mL) significantly increased 
expression of Bax, a pro-atretic factor, compared to DMSO beginning at 24hrs and continuing 
throughout culture [Figure 4.11; Panel A].  BPA (1µg/mL) and BPA (10µg/mL) did not significantly affect 
Bax expression compared to DMSO at any time point.  Similarly, exposure to BPA (100µg/mL) 
significantly increased expression of Bcl2, an anti-atretic factor, compared to DMSO beginning at 24hrs 
and continuing throughout culture [Figure 4.11; Panel B].  BPA (1µg/mL) and BPA (10µg/mL) did not 
significantly affect Bcl2 expression compared to DMSO at any time point. 
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4.5 Discussion 
Consistent with this current study, previous work by our group has shown that in vitro BPA 
exposure inhibits antral follicle growth [24]. However, the current study expands previous studies by 
showing that BPA does not work through genomic estrogen receptors to inhibit follicle growth.  Though 
BPA binds with less affinity than estradiol to ESR1 [33-35] and ESR2 [34;34], studies have shown that 
BPA acts through genomic estrogen receptors in other cell types.  BPA induces Esr1 expression in fetal 
mouse mesenchyme cells [36], induces Esr1 expression and estrogen responsive proteins in the female 
rat uterus [33], and induces activation of estrogen response elements in Hep2G cells [33] and pituitary, 
stimulating ESR-dependent prolactin release and cell proliferation in the pituitary [33].  In our study, 
Esr1 expression was up-regulated in the follicles with inhibited growth at 24hrs, but then down-
regulated at 72hrs, indicating BPA has an effect on Esr1, but this effect is partially time-dependent.  
Further, though 10µg/mL BPA did not significantly inhibit follicle growth, exposure to 10µg/mL BPA 
increased Esr2 expression beginning at 24hrs and continuing throughout culture.   Granulosa cell 
proliferation and follicle growth are driven by ESR2 [37], thus up-regulation of Esr2 may have protected 
these follicles from BPA-induced growth inhibition by promoting granulosa cell proliferation.   
After identifying that BPA increases expression of Esr1 in follicles with inhibited growth, we 
wanted to determine if BPA works through this receptor.  Previous studies have shown that estradiol 
can displace BPA from ESR1 in competitive binding assays [34] and that ICI can block Esr1 activation by 
BPA in Hep2G cells transfected with Esr1 [33].  Further, overexpression of Esr1 can increase the 
susceptibility of follicles to growth inhibition after exposure to other endocrine disrupting chemicals, 
such as methoxychlor [30].  Thus, we hypothesized that inhibition of follicle growth is mediated through 
Esr1 and addition of estradiol and ICI would protect the follicles from BPA-induced inhibition of follicle 
growth.  Further, overexpression of Esr1 would make follicles more susceptible to BPA.  However, 
neither co-treatment of estradiol nor pre-treatment with ICI prevented BPA from inhibiting follicle 
growth.  Additionally, overexpression of Esr1 did not increase the sensitivity of follicles to BPA-induced 
follicle growth inhibition.   
 Though our data indicate that BPA does not inhibit follicle growth directly through the genomic 
estrogenic pathway, BPA does affect Esr1 and Esr2 expression, and thus, may mediate estrogenic effects 
in the follicle.  Other studies have shown that BPA quickly acts through the non-genomic estrogen 
responsive GPR30 and ERK pathways in breast cancer cells and, similar to our results, these effects could 
not be prevented by ICI [8].  Therefore, we speculate that BPA may inhibit follicle growth through a non-
genomic estrogenic pathway, though further studies are needed to confirm this hypothesis. 
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Previous studies have shown that follicle growth is not always dependent on hormone 
production by follicles.  Specifically, previous studies indicate BPA (10µg/mL) inhibits steroidogenesis 
without affecting follicle growth [24].  Thus, we examined other mechanisms by which BPA inhibits 
follicle growth.  Morphological examination of the follicles over time indicated striking differences 
between control and BPA treated follicles [Figure 4.3].  The control follicles readily changed in shape and 
expanded in size, whereas the follicles treated with 100µg/mL BPA seemed suspended in time, or 
frozen; they did not grow or change in size or appearance outside of becoming more opaque.  Follicle 
growth is dependent on granulosa cell proliferation and this is regulated, in part, by the cell cycle [26].  
Therefore, we considered the possibility that this suspension/inhibition of growth by BPA is due to BPA 
affecting the cell cycle.  The cell cycle is a dynamic process of DNA replication and cell division and 
separated by growth phases [26;27].  In these phases, the cells grow in size and replicate their cytosolic 
contents in preparation for cell division, and thus, proliferation [26].  Estrogenic endocrine disruptors 
can inhibit follicle growth by down-regulating expression of cell cycle regulators during the G1-S 
transition [38].  However, in this study, while BPA down-regulated Ccnd2 at 48hrs, BPA up-regulated cell 
cycle regulators Cdk4, Ccne1, and the inhibitor Trp53 beginning at 24hrs and continuing throughout 
culture [Figure 4.12].  Similar to our studies, others have shown that BPA affects the cell cycle of 
follicular cells.  BPA inhibits cell cycle progression in oocytes [39] and reduces granulosa cell proliferation 
of early pre-antral follicles in vitro [40].   Though the up-regulation of Cdk4 and Ccne1 should favor cell 
proliferation and, therefore, these factors should be down-regulated in quiescent follicles, up-regulation 
of Trp53 coupled with the down-regulation of Ccnd2, might be preventing cell proliferation, explaining 
the inhibited growth and stalled appearance in BPA treated follicles [26].   
In addition to examining whether BPA inhibits follicle growth by affecting cell cycle regulators, 
we examined whether BPA could inhibit growth because it induces atresia.  We found that BPA 
(100µg/mL) induced atresia beginning at 48hrs in culture, 24hrs before follicle growth was inhibited 
compared to DMSO controls [Figure 4.12].  This is the same concentration that inhibits follicle growth, 
suggesting that follicles are not growing because they are dying.  The BCL2 family mediates atresia and 
helps determine if cells within the follicle will remain healthy or undergo atresia [19;27;28;41].  It is 
comprised of numerous proteins that are either pro-apoptotic, such as BAX, or anti-apoptotic, such as 
BCL2.  We found that BPA (100µg/mL) induced Bax beginning at 24hrs and continuing throughout 
culture [Figure 4.12].  Unexpectedly, BPA (100µg/mL) also induced Bcl2 expression beginning at 24hrs 
[Figure 4.12].  These findings correspond with other studies showing that BPA arrests the cell cycle, 
while also dysregulating atresia factors and inducing cell death in isolated granulosa cells [28].  This 
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increase in Bcl2 as well as Bax was surprising because it is well known that a higher Bax:Bcl2 ratio will 
promote atresia, whereas a high Bcl2:Bax ratio promotes survival because BCL2 binds to and inactivates 
BAX [42].  However, in this study, a higher Bcl2 :Bax ratio does not protect the follicles from atresia.   It is 
possible that follicles may up-regulate Bcl2 to try and prevent atresia, but that this rescue attempt is 
unsuccessful.  We also found that BPA (100µg/mL) induced Trp53, a direct transcriptional regulator of 
Bax [42] beginning at 24hrs and continuing throughout culture.  Therefore, BPA may trigger the atresia 
pathway, stimulating the up-regulation of Trp53 and the pro-atresia pathway.  These actions ultimately 
inhibit follicle growth and induce atresia despite attempts to promote survival by up-regulating Bcl2.   
It is well understood that the oocyte and somatic cells of ovarian follicles bi-directionally 
regulate each other for proper oocyte maturation and somatic cell proliferation and differentiation [43].  
In these studies, the effects of BPA on the oocyte were not measured.  Though the effects of BPA in both 
the oocyte and the surrounding follicles have been investigated separately, there are no studies 
investigating if the effects of BPA originate in the oocyte or the somatic cells.  In isolated granulosa cells, 
BPA exposure within 24-72h resulted in arrested mitosis of the granulosa cells [26].  Numerous studies 
have shown BPA affects the oocytes, though these effects range from 16h [13] to 7 days [16].  Further 
studies are needed to accurately assess if BPA effects originate in the somatic cells or in the oocyte.   
The implications of our findings may be relevant to humans. Though the highest dose used in 
this study, BPA (100µg/mL), is higher than some other observed concentrations in other fluids and 
placental tissues, it is not known how much BPA is found in antral follicles and it is possible 
concentrations could reach these levels.  Antral follicles are highly vascularized structures, potentially 
exposed constantly to BPA released from bioaccumulation in fatty tissues surrounding the ovaries [44].  
Studies have shown that levels of BPA in fatty tissues can be higher than those measured in the serum 
[45;46].  Further, humans are constantly exposed to BPA, indicated by the presence of BPA in 93-96% of 
urine samples taken in various studies.  An estimated daily intake of BPA ranged from 0.6–71.4 μg/day, 
though this is only an estimate using urine samples taken in the morning from human study subjects and 
could be higher [1;4].   Though this is only speculation, bioaccumulation in fat is highly likely, making 
levels of BPA used in our study plausible for human exposure. This may be particularly important 
because studies indicate that some women undergoing IVF treatment have high levels of BPA [47] 
 Overall, this study shows that exposure to BPA inhibits growth and induces atresia in antral 
follicles.  Future studies should examine whether BPA affects follicle growth and atresia in humans. 
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4.6 Figures and Legends 
 
Figure 4.1 Interaction between cell cycle regulators and atresia factors 
 
 
 
The cell cycle is mediated by cell cycle regulators and consists of 4 stages: Growth 1 (G1), synthesis (S), 
growth 2 (G2), and Mitosis (M).  Cell cycle regulators and atresia factors can be intertwined. Complexes 
of cyclin-dependent kinase 4 (CDK4) with cyclin D2 (CCND2) and cyclin-dependent kinase 2 (CDK2) with 
cyclin E1 (CCNE1) regulate cell progression through G1 phase and permit entrance into S phase, driving 
cell proliferation and follicle growth.  However, tumor repressor protein 53 (TRP53) can inhibit 
progression from G1 to S phase, arresting cell proliferation.  Further, TRP53 can initiate atresia by 
activating Bcl2-associated X protein (BAX).  Conversely, cells can promote survival and inhibit atresia by 
activating B-cell lymphoma factor 2 (BCL2), which can bind to BAX, inhibiting atresia. 
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Figure 4.2 Effect of BPA on follicle growth 
 
 
 
Antral follicles were mechanically isolated from FVB mice and exposed in vitro to DMSO or BPA (10-
100µg/mL) for 24-120hrs.  Growth of follicles was monitored during culture, recorded in micrometers, 
and reported as percent change.  The graph represents means ± SEMs from at least three separate 
experiments.  Lines with asterisks (*) are significantly different from DMSO controls (n= 8-16 follicles per 
treatment per experiment from at least three separate experiments; p≤0.05). 
  
72 
 
 
Figure 4.3 Effect of BPA on morphology 
 
 
 
Antral follicles were mechanically isolated from FVB mice and exposed in vitro to DMSO or BPA 
(100µg/mL) for 24-96hrs.  Growth of follicles was observed as described in Materials and Methods. 
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Figure 4.4 Effect of BPA exposure on Esr1 and Esr2 mRNA expression levels   
  
 
 
After exposure of antral follicles to DMSO control or BPA (1-100µg/mL) for 24-96hrs in vitro, the follicles 
were collected and subjected to qPCR analysis for A) Esr1 and B) Esr2 mRNA expression levels.  All values 
were normalized to beta-actin as a loading control.  The graphs represent means ± SEMs from at least 
three separate experiments.  Asterisk (*) indicates p≤0.05 from DMSO control. 
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Figure 4.5 Effect of Estradiol and ICI on BPA-induced follicle growth inhibition 
  
 
 
Antral follicles were mechanically isolated from FVB mice and exposed in vitro to A) DMSO, BPA (10-
100µg/mL), estradiol (10nM), or BPA (10-100µg/mL)+estradiol (10nM) or  B) DMSO, BPA (100µg/mL), ICI 
(1µM), or BPA (100µg/mL)+ICI (1µM) for 24-120hrs. Growth of follicles was monitored during culture, 
recorded in micrometers, and reported as percent change.  The graphs represent means ± SEMs from at 
least three separate experiments.  Lines with asterisks (*) are significantly different from DMSO controls 
(n= 8-16 follicles per treatment per experiment from at least three separate experiments; p≤0.05). 
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Figure 4.6 Effect of over-expressing Esr1 on susceptibility to BPA-induced follicle growth inhibition 
  
 
 
Antral follicles were mechanically isolated from A) control or B) over-expressing Esr1 mice and exposed 
in vitro to DMSO or BPA (10-100µg/mL) for 24-120hrs. Growth of follicles was monitored during culture, 
recorded in micrometers, and reported as percent change.  The graphs represent means ± SEMs from at 
least three separate experiments.  Lines with asterisks (*) are significantly different from DMSO controls 
(n= 8-16 follicles per treatment per experiment from at least three separate experiments; p≤0.05). 
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Figure 4.7 Effect of BPA on Cdk4 and Ccnd2 mRNA expression levels 
 
 
 
After exposure of antral follicles to DMSO control or BPA (1-100µg/mL) for 24-96hrs in vitro, the follicles 
were collected and subjected to qPCR analysis for A) Cdk4 and B) Ccnd2 mRNA expression levels.  All 
values were normalized to beta-actin as a loading control.  Graphs represent means ± SEMs from at least 
three separate experiments.  Asterisk (*) indicates p≤0.05 from DMSO control. 
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Figure 4.8 Effect of BPA on Ccne1 and Trp53 mRNA expression levels 
 
 
 
After exposure of antral follicles to DMSO control or BPA (1-100µg/mL) for 24-96hrs in vitro, the follicles 
were collected and subjected to qPCR analysis for A) Ccne1 and B) Trp53 mRNA expression levels.  All 
values were normalized to beta-actin as a loading control.  Graphs represent means ± SEMs from at least 
three separate experiments.  Asterisk (*) indicates p≤0.05 from DMSO control. 
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Figure 4.9 Effect of BPA on atresia morphology 
 
 
 
After exposure to A,C) DMSO, B,D) BPA (100µg/mL), E) estradiol (10nM), or F) BPA (100µg/mL)+estradiol 
10nM for 48 and/or 120hrs, antral follicles were removed from culture and atresia was observed as 
described in Materials and Methods.  Red arrows indicate apoptotic bodies.  Asterisk (*) indicates 
p≤0.05 from DMSO control.  Original magnification 40x. 
79 
 
 
Figure 4.10 Effect of BPA on atresia  
 
 
 
After exposure to A) DMSO or BPA (100µg/mL) for 48- 120hrs or B) DMSO, BPA (10-100µg/mL), estradiol 
(10nM), or BPA (10-100µg/mL)+estradiol 10nM for 120hrs, antral follicles were removed from culture 
and processed for histological evaluation of atresia as described in Materials and Methods. Atresia of 
follicles was reported as a rating per treatment group.   Graph represents means ± SEMs from at least 
three separate follicles per treatment group.  Asterisk (*) indicates p≤0.05 from DMSO control.     
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Figure 4.11 Effect of BPA on Bax and Bcl2 mRNA expression levels 
 
 
 
After exposure of antral follicles to DMSO control or BPA (1-100µg/mL) for 24-96hrs in vitro, the follicles 
were collected and subjected to qPCR analysis for A) Bax and B) Bcl2 mRNA expression levels.  All values 
were normalized to beta-actin as a loading control.  Graphs represent means ± SEMs from at least three 
separate experiments.  Asterisk (*) indicates p≤0.05 from DMSO control. 
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Figure 4.12 Schematic of observed effects of BPA on gene expression, follicle growth inhibition, and 
atresia 
 
 
 
This schematic illustrates that at 24hrs, BPA significantly increases expression of Cdk4, Ccne1, Trp53, 
Bax, and Bcl2.  At 48hrs, BPA significantly decreases Ccnd2 and induces atresia.  Between 72-120hrs, BPA 
significantly inhibits follicle growth and induces atresia. 
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CHAPTER V 
 
BPA acutely and reversibly down-regulates Cyp11a1, leading to a reversible decrease in sex steroid 
hormone production in cultured mouse antral follicles 
 
5.1 Abstract 
Bisphenol A (BPA) is the backbone of commonly used polycarbonate plastic products and the 
epoxy resin lining of aluminum cans.  Previous studies have shown that exposure to BPA decreases sex 
steroid hormone production in mouse antral follicles.  The current study tests the hypothesis that BPA 
first decreases the mRNA expression levels of the steroidogenic enzyme cytochrome P450 side-chain 
cleavage (Cyp11a1) and steroidogenic acute regulatory protein (StAR) in mouse antral follicles, leading 
to a decrease in sex steroid hormone production in vitro.  Further, the current study tests the hypothesis 
that these effects are acute and reversible after removal of BPA.  Exposure to BPA (10μg/mL and 
100μg/mL) decreased expression of Cyp11a1 and StAR beginning at 18h and 72h, respectively, 
compared to controls.  Exposure to BPA (10μg/mL and 100μg/mL) significantly decreased progesterone 
levels beginning at 24h and decreased androstenedione, testosterone, and estradiol levels at 72h and 
96h compared to controls.  Further, after removing BPA from the culture media at 20h, expression of 
Cyp11a1 and progesterone levels were restored to control levels by 48h.  Additionally, expression of 
StAR and levels of androstenedione, testosterone, and estradiol never decreased compared to controls.  
These data suggest that BPA acutely decreases expression of Cyp11a1 as early as 18h and this reduction 
in Cyp11a1 leads to a decrease in progesterone production by 24h, followed by a decrease in 
androstenedione, testosterone, and estradiol production and decreased expression of StAR at later time 
points.  Therefore, BPA exposure initially targets Cyp11a1 and steroidogenesis, but these effects are 
reversible with removal of BPA exposure. 
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5.2 Introduction 
Bisphenol A (BPA) is a mass-produced chemical used in the manufacturing of polycarbonate 
plastics and epoxy resins, as well other commonly used materials such as receipt paper and dental 
sealants.  Humans are constantly exposed to BPA because it is present in food and drinks after leaching 
from polycarbonate containers or aluminum cans.  Various studies have detected BPA in human blood, 
urine, fat, mammary tissue, and the placenta (Calafat et al., 2005; Ikezuki et al., 2002;Ouchi et al., 2002; 
Vandenberg et al., 2007).  BPA can also reach the ovary and has been found in aspirated antral fluid of 
women undergoing in vitro fertilization treatment (Ikezuki et al., 2002).   Once in the body, BPA can act 
as an endocrine disruptor, impairing processes such as sexual development (Kubo et al., 2003; 
Vandenberg et al., 2006), behavior (Fujimoto et al., 2006) and reproductive functioning.  Few studies, 
however, have examined the effects of BPA on the ovary, and even fewer studies have examined the 
effects of BPA on adult antral follicles. 
The follicle is the functional unit of the ovary.  There are various stages of follicles that develop 
in cycles over the reproductive lifespan of a female: primordial, primary, pre-antral/secondary, and 
antral (Williams et al., 2012).  The antral follicles are the main producers of sex steroid hormones, which 
are required for normal reproductive function as well as overall female health.  Estradiol, for example, is 
required for estrous cyclicity (Glidewell-Kenney et al., 2007), proper bone health (Bagur et al., 1992), 
cardiovascular health (Hu FB et al., 1999), and brain functioning (Birge SJ, 1998).  While the adrenal 
glands produce some sex steroid hormones, the majority of hormones in the female are produced by 
the follicles in the ovary. 
Estradiol is the terminal sex steroid hormone produced in the estradiol biosynthesis pathway.  In 
this pathway, cholesterol is brought into the mitochondria of thecal cells by steroidogenic acute 
regulatory protein (StAR), where it is metabolized into pregnenolone by cytochrome P450 side chain 
cleavage (Cyp11a1).  Both StAR and Cyp11a1 are considered rate-limiting factors for steroidogenesis 
because their activities provide the necessary precursor for the rest of the hormones in the pathway, 
pregnenolone (LaVoie and King, 2009; Stocco and Clark, 1996b).  In antral follicles, pregnenolone is 
further converted into hormones such as progesterone, androstenedione, and testosterone in the thecal 
cells, and then converted to estradiol in the granulosa cells by various enzymes in the pathway, such as 
3β-hydroxysteroid dehydrogenase, 17β- hydroxysteroid dehydrogenase, and cytochrome P450 
aromatase.  
Follicular development to mature antral follicles and ovulation is mediated by positive and 
negative feedback of hormones throughout the menstrual or estrous cycle (Rajkovic et al., 2006).   
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Further, uterine readiness for implantation and maintenance of pregnancy are dependent on proper 
hormonal signals (Cha et al., 2012; LaVoie and King, 2009).  Thus, disruption of steroidogenesis and 
hormones will have deleterious effects on successful reproduction.   
We have previously shown that exposure of antral follicles to BPA (10µg/mL and 100µg/mL) 
decreases levels of progesterone, dehydroepiandrosterone, androstenedione, estrone, testosterone, 
and estradiol produced by antral follicles after 120h in culture compared to controls, while a lower dose 
of BPA (1µg/mL) had no effect on hormone levels (Peretz et al. 2011).  In addition, our previous studies 
show that BPA (10µg/mL and 100µg/mL) decreases expression of StAR and Cyp11a1 after 120h in 
culture, but it does not affect the other enzymes in the estradiol biosynthesis pathway compared to 
controls.  We further confirmed this by showing that co-culturing BPA-treated follicles with 
pregnenolone protected the follicles from BPA-induced hormone inhibition.   
Previous studies, however, did not determine the time-course of BPA-induced inhibition of 
steroidogenesis.  Thus, we do not know how rapidly BPA inhibits steroidogenesis.  Further, previous 
studies did not determine whether BPA first inhibits StAR or Cyp11a1 and how this inhibition relates to 
the observed reduction in hormone levels.  Finally, previous studies only examined the effects of chronic 
exposure to BPA on steroidogenic gene expression and hormone levels.   Thus, we do not know if acute 
exposure to BPA has similar effects to those observed with chronic exposure and whether the effects of 
BPA on the antral follicles are reversible.  Therefore, the goals of the current study were to: 1) 
determine how quickly BPA exposure inhibits expression of steroidogenic enzymes and sex steroid 
hormone levels in mouse antral follicles, 2) determine whether BPA exposure first targets StAR or 
Cyp11a1, and 3) determine if the effects of BPA on the antral follicle are reversible.  We specifically 
tested the hypothesis that BPA exposure rapidly inhibits StAR and Cyp11a,  leading to rapid decline in 
sex steroid hormone levels.  We also tested the hypothesis that the effects of BPA on StAR and Cyp11a1 
expression and hormone levels are reversible.  
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5.3 Materials and Methods 
Chemicals: BPA powder (99%) was purchased from Sigma-Aldrich (St. Louis, MO).  A stock solution of 
BPA was dissolved and diluted in the vehicle dimethyl sulfoxide (DMSO; Sigma-Aldrich) to achieve BPA 
treatment concentrations of 1.3, 13.3 and 133mg/mL for final working concentrations of 1.0, 10, and 
100µg/mL BPA in the culture media.  Using these treatment concentrations allowed each working 
concentration to contain the same final concentration of vehicle (0.075% DMSO). 
The concentrations chosen were based on previous studies, which indicate that 1 and 10µg/mL BPA do 
not inhibit follicle growth or induce atresia, but that 10µg/mL BPA decreases hormone levels (Peretz et 
al., 2011).  Thus, at 10µg/mL BPA, the observed effects on hormone production are due to direct effects 
on steroidogenesis and not due to inhibited follicle growth or increased atresia.  The selected 
concentrations of BPA are relevant to current regulatory levels set for BPA and can be considered low 
doses.  The lowest observable adverse effects level (LOAEL) and the lowest dose investigated for 
regulatory studies is 50mg/kg/day (National Toxicology Program, 1982).  This equates to approximately 
50µg/mL in culture, and our selected doses of 1 and 10µg/mL BPA are 50 and 5 times lower than the 
LOAEL, respectively. 
 
Animals: Adult cycling CD-1 mice were purchased from Charles River (Wilmington, MA) and allowed to 
acclimate to the facility for at least 5 days before use.  The mice were housed at the University of Illinois 
at Urbana-Champaign, Veterinary Medicine Animal Facility.  Food (Harlan Teklad: 8626) and water were 
provided for ad libitum consumption.  Temperature was maintained at 22±1°C and animals were 
subjected to 12h light-dark cycles.  The Institutional Animal Use and Care Committee at the University of 
Illinois at Urbana-Champaign approved all procedures involving animal care, euthanasia, and tissue 
collections. 
 
Time-Course Cultures: Female CD-1 mice were euthanized on postnatal day (PND) 32-35 and their 
ovaries removed using aseptic technique.  Antral follicles were mechanically isolated from the ovary 
based on relative size (250-400 µm), cleaned of interstitial tissue using fine watchmaker forceps, and 
individually placed in wells of a 96-well culture plate, and covered with un-supplemented α-minimal 
essential medium (α-MEM) prior to treatment. Sufficient numbers of antral follicles for statistical power 
were isolated from unprimed mouse ovaries; follicles from 2–3 mice were isolated per experiment 
providing approximately 20–40 antral follicles from each mouse.  Each experiment contained a 
minimum of 8–12 follicles per treatment group. Doses of vehicle control (DMSO) and BPA (1, 10, and 
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100µg/mL) were individually prepared in α-MEM supplemented media.  Supplemented α-MEM was 
prepared with: 1% ITS (10 ng/ml insulin, 5.5 ng/ml transferrin, 5.5 ng/ml selenium), 100 U/ml penicillin, 
100 mg/ml streptomycin, 5 IU/ml human recombinant follicle-stimulating hormone (FSH; Dr. A. F. 
Parlow, National Hormone and Peptide Program, Harbor- UCLA Medical Center, Torrance, CA), and 5% 
fetal calf serum (Atlanta Biologicals, Lawrenceville, GA).  An equal volume of chemical was added for 
each dose to control for the amount of vehicle in each preparation (0.75 µL/mL of media: BPA 
treatments; 1.0 µL/mL of media: DMSO treatment).  Antral follicles were cultured for 6h, 12h, 18h, 19h, 
24h, 48h, 72h, or 96h in an incubator supplying 5% CO2 at 37°C. After cultures, follicles were snap-frozen 
in liquid nitrogen and subjected to quantitative PCR (qPCR) as described below.  Media were collected 
and stored at -80°C until subjected to hormone assays as described below. 
  
BPA Recovery Cultures:  To evaluate if removal of BPA from the culture media would rescue follicles 
from  the BPA-induced inhibition of hormones and decreased expression of StAR and Cyp11a1, female 
CD-1 mice were euthanized on PND32-35 and follicles isolated by aseptic technique based on relative 
size (250-400µm).  Individual follicles were cleaned of interstitial tissue using fine watchmaker forceps 
and placed in wells of a 96-well culture plate, as described above. Doses of vehicle control (DMSO) and 
BPA (1µg/mL and 10µg/mL) were individually prepared in supplemented α-MEM as described above.  
We did not use 100µg/mL BPA in these experiments because our previous study indicates that it causes 
atresia, whereas 1 and 10µg/mL BPA do not cause atresia (Peretz et al., 2011).  Therefore, by omitting 
100µg/mL BPA, we can distinguish direct effects of BPA on steroidogenesis from indirect effects on 
steroidogenesis due to BPA-induced atresia.  Antral follicles were cultured with BPA for 20h in an 
incubator supplying 5% CO2 at 37°C.  We cultured follicles in BPA for 20h because our experiments 
indicated that BPA inhibits expression of Cyp11a1 by 18h in culture and we wanted to test if removal of 
BPA could recover both the decrease in gene expression and decrease in hormone levels over time.   At 
20h, media from the BPA treated groups were removed and replaced with supplemented α-MEM with 
DMSO at a concentration identical to the vehicle control group.  After the media change, follicles were 
cultured for 4h, 28h, 52h, and 76h more hours to mimic the 24h, 48h, 72h, and 96h total culture times 
used in previous studies (Peretz et al., 2011).   
 
Analysis of hormone levels:  Media were collected after 20h, 24h, 48h, 72h, and 96h of follicle culture 
and subjected to enzyme-linked immunosorbent assays (ELISA) for measurement of progesterone, 
androstenedione, testosterone, and estradiol levels.  ELISA kits were obtained from DRG Instruments 
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GmbH (Marburg, Germany).  The assays were run using the manufacturer’s instructions.   All samples 
were run in duplicate and all intra- and inter-assay coefficients of variability were less than 10%. 
  
Analysis of gene expression by quantitative real-time PCR:  Antral follicles were cultured as described 
above.  To evaluate when expression of StAR and Cyp11a1 were altered in the BPA time-course or 
recovery cultures, follicles were collected and snap-frozen in liquid nitrogen for qPCR analysis.  Total 
RNA was extracted from follicles using the RNeasy Micro Kit (Qiagen, Inc., Valencia, CA) according to the 
manufacturer’s protocol.  Reverse transcriptase generation of complementary DNA (cDNA) was 
performed with 0.5µg of total RNA using an iScript RT Kit (Bio-Rad Laboratories, Inc., Hercules, CA). qPCR 
was conducted using the CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories) and 
accompanying software (CFX Manager Software) according to the manufacturer’s instructions.  The 
amount of PCR product generated was quantified by measuring a dye (SYBR Green) that fluoresces 
when bound to double-stranded DNA.  A standard curve was generated from five serial dilutions of a 
compilation of the samples, thus allowing analysis of the amount of cDNA in the exponential phase.  
qPCR analysis was performed using 2µL cDNA, EvaGreen, and forward and reverse primers for StAR 
(NM_011485.4) and Cyp11a1 ( NM_019779.3).  An initial incubation of 95°C for 10 minutes (min) was 
followed by 94°C for 10 seconds(s), annealing at 60°C for 10s, and extension at 72°C for 10s, for 40 
cycles, followed by a final extension at 72°C for 10min.  A melting curve was generated at 55-90°C to 
monitor the generation of a single product.  The software also generated a standard curve, made from 
cDNA of samples within the experiment.  β-actin (Actb; NM_007393) was used as a reference gene for 
each sample.  Final values were calculated and expressed as the ratio normalized to Actb.  All analyses 
were performed in duplicate for at least three separate experiments. 
 
Statistical Analysis:   Data were expressed as means ± standard error of the mean (SEM), and multiple 
comparisons between experimental groups were made using generalized linear model (GLM) univariate 
analysis and/or analysis of variance (ANOVA) followed by Tukey’s or Games-Howell post hoc 
comparisons, when appropriate.  At least three separate experiments were conducted for each 
treatment prior to data analysis.  Statistical significance was assigned at p≤ 0.05. 
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5.4 Results 
Effect of BPA on sex steroid hormone production over time:  In previous studies, we have shown that 
BPA inhibits steroidogenesis at 120h in culture (Peretz et al., 2011), but we did not conduct time-course 
experiments and thus, did not know how rapidly BPA inhibits sex steroid hormone levels. Therefore, to 
test when BPA decreases levels of each hormone over time, we collected the media from the time-
course study at 24h, 48, 72h, and 96h.  At each time-point, levels of progesterone, androstenedione, 
testosterone, and estradiol were measured using ELISA. Exposure to BPA (10µg/mL and 100µg/mL) 
significantly decreased progesterone levels compared to control from 24-96h and significantly 
decreased androstenedione, testosterone, and estradiol levels compared to control from 72-96h (Figure 
5.1).  BPA (1µg/mL) significantly decreased progesterone levels at 24h, but did not significantly decrease 
progesterone levels compared to control at any other time-point.  Further, BPA (1µg/mL) did not 
significantly decrease androstenedione, testosterone, or estradiol at any time-point compared to 
control.   
 
Effect of BPA on expression of StAR and Cyp11a1 over time:  StAR and Cyp11a1 are the rate-limiting 
enzymes for the estradiol biosynthesis pathway in the follicles.  StAR is required to transport cholesterol 
into the inner mitochondrial membrane where Cyp11a1 is present to convert cholesterol into 
pregnenolone, the sex steroid hormone precursor.  If these are down-regulated, steroidogenesis will be 
impaired, preventing pregnenolone from being synthesized and metabolized into other hormones 
within the estradiol biosynthesis pathway.  Previous studies have shown that BPA decreased StAR and 
Cyp11a1 expression at 120h in culture (Peretz et al., 2011).  Therefore, we expanded on these findings 
by testing when these factors are initially decreased over time. 
BPA (10 and 100µg/mL) significantly decreased expression of StAR compared to control 
beginning at 72h and continuing throughout 96h (Figure 5.2).  Further, BPA (10 and 100µg/mL) 
significantly decreased expression of Cyp11a1 beginning at 24h and continuing throughout 96h (Figure 
5.2).  BPA (1µg/mL) did not significantly decrease expression of StAR and Cyp11a1 compared to control. 
Since BPA (10µg/mL) decreased expression of Cyp11a1 and progesterone at 24h, we wanted to 
determine if expression of Cyp11a1 was decreased any sooner, indicating BPA first decreases Cyp11a1 
and then progesterone levels.  To test if BPA decreased expression of Cyp11a1 earlier than 24h, we 
collected follicles from the time-course study at 6h, 12h, 18h, and 19h and subjected them to qPCR for 
Cyp11a1 gene expression analysis.  Exposure to BPA (100µg/mL) decreased expression of Cyp11a1 as 
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early as 6h compared to control (Figure 5.3).  Exposure to BPA (10µg/mL) significantly decreased 
expression of Cyp11a1 as early as 18h compared to control (Figure 5.3). 
 
Effect of removing BPA from culture on expression of StAR and Cyp11a1:  To determine if the effects of 
BPA are acute or chronic, we performed BPA recovery cultures.  Acute BPA (10µg/mL) exposure for 20h 
did not significantly affect expression of StAR at any time-point in the culture (Figure 5.4).  Acute BPA 
(10µg/mL) exposure for 20h significantly inhibited Cyp11a1 expression at 24h (Figure 5.4).  However, 
removal of BPA (10µg/mL) from the culture resulted in normal expression of Cyp11a1 by 48h (Figure 4).  
Acute BPA (1µg/mL) exposure for 20h did not affect expression of StAR and Cyp11a1 at any time-point 
compared to control (Figure 5.4). 
 
Effects of removing BPA from culture on sex steroid hormone production:  To test whether removing 
BPA from the cultures after 20h would restore hormone levels back to control levels, media were 
collected at 24h, 48h, 72h, or 96h total times in culture (or 4h, 28h, 52h, or 76h after BPA removal, 
respectively) and subjected to ELISA.  Acute BPA (10µg/mL) exposure for 20h significantly decreased 
progesterone levels at 24h (Figure 5.5).  However, removal of BPA (10µg/mL) from the culture resulted 
in normal levels of progesterone by 48h (Figure 5.5).  Acute BPA (1µg/mL and 10µg/mL) exposure for 
20h did not affect androstenedione, testosterone, or estradiol levels at any time-point compared to 
control (Figure 5.5). 
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5.5 Discussion 
The results of our study indicate that BPA targets and decreases expression of Cyp11a1 prior to 
decreasing hormone production.  BPA decreased Cyp11a1 beginning at 18h in culture and this continued 
throughout the culture period.   Following the decrease in Cyp11a1 expression, progesterone levels 
were decreased beginning at 24h and continuing throughout the culture period.  Then, likely due to a 
lack of precursor hormone, androstenedione, testosterone, and estradiol levels decreased at 72h and 
96h compared to controls.  In addition, our data suggest that due to a lack of cholesterol conversion to 
pregnenolone without Cyp11a1, StAR is down-regulated at 72h to prevent a cholesterol build-up in the 
inner mitochondrial membrane.  Further, these effects of BPA are reversible once BPA is removed from 
the culture media.  BPA was removed after 20h of culture, long enough to ensure that expression of 
Cyp11a1 was decreased, and replaced by BPA-free media.  Follicles were cultured until 24h, 48h, 72h, or 
96h total time in culture to evaluate if the follicles could recover Cyp11a1 expression, as well as produce 
normal levels of hormones.  Expression of Cyp11a1 was recovered compared to control by 48h and 
expression of StAR never decreased compared to control.  Further, progesterone levels returned to 
control levels by 48h, and androstenedione, testosterone, and estradiol levels never decreased 
compared to controls.   
The effects of BPA on steroidogenesis in antral follicles may be reversible because of how StAR 
and Cyp11a1 are regulated.  Positive transcriptional regulation of StAR and Cyp11a1 in the ovary is 
controlled by cyclic-AMP dependent signaling pathways mediated through steroidogenic factor-1 and 
liver receptor homolog-1 (Amsterdam et al., 2003; Shih et al., 2011; Stocco and Clark, 1996a; Stocco and 
Clark, 1996b).  Negative transcription regulation is controlled by factors such as prostaglandin F2α, 
lipopolysaccharide-induced endotoxemia, tumor necrosis factor α, activin A, extracellular signal-
regulated kinase (ERK), and Dax-1 (LaVoie and King, 2009; Stocco and Clark, 1996b).  Further, Dax-1 has 
been shown to inhibit SF-1 expression, which is required for StAR expression (Amsterdam et al., 2003; 
LaVoie and King, 2009), and to directly down-regulate Cyp11a1 expression (LaVoie and King, 2009).  BPA 
has been shown to activate ERK and other cyclic-AMP dependent signaling factors in mouse 
hippocampal cells (Lee S et al., 2008) as well as to up-regulate expression of the gene encoding Dax-1, 
Nr0B1, in the brain and gonads of self-fertilizing fish (Rhee et al., 2011).   As a result, BPA may decrease 
expression of Cyp11a1 and StAR through ERK or Dax-1 signaling pathways and second messenger 
signals, not by permanently impairing regulatory elements of each gene.  Thus, removal of BPA may 
restore these pathways to their normal activities and, as our study indicates, the effects of BPA may be 
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reversible.  Further studies on ERK and Dax-1 on BPA-inhibited steroidogenesis in antral follicles are 
warranted.    
Steroidogenesis is a tightly controlled, essential process for the development of antral follicles 
and overall female reproduction (Cain et al., 1995).  All downstream hormones in the estradiol 
biosynthesis pathway, such as estrone and estradiol, are dependent on the presence or availability of 
upstream hormones such as testosterone, androstenedione, and progesterone.  In addition, metabolism 
of these hormones through the pathway is dependent on steroidogenic enzymes such as Cyp11a1, 3β-
hydroxysteroid dehydrogenase, aromatase, and steroidogenic protein StAR.  Without StAR, no 
cholesterol will be transported into the inner mitochondrial membrane (Stocco and Clark, 1996b).  
Further, without Cyp11a1 and thus, the conversion of cholesterol to pregnenolone, no further 
downstream hormones, such as progesterone, will be synthesized in the pathway (Simpson, 1979).  Our 
study has shown that BPA decreases the expression of Cyp11a1 after 18h of culture.  By preventing the 
conversion of cholesterol to pregnenolone, thecal cells cannot synthesize progesterone and, so, by 24h, 
BPA exposure decreases progesterone levels.  By 72h, the levels of androstenedione, testosterone, and 
estradiol, the downstream hormones dependent on the presence of progesterone, decrease as well, 
mostly likely for lack of available progesterone.  We have previously shown that hormone levels can be 
rescued during exposure to BPA if precursor hormone, pregnenolone, was added to the cultures (Peretz 
et al., 2011), further supporting our hypothesis and these results.  
Our results are consistent with data from human studies showing that BPA exposure may be 
associated with altered hormone levels in both males and females.  BPA has been inversely associated 
with estradiol levels in women undergoing IVF (Ehrlich et al., 2012; Mok-Lin E et al., 2010), positively 
associated with androgen levels in women with polycystic ovarian syndrome (Kandaraki et al., 2011), 
and positively associated with decreases in the ratio of estradiol to testosterone in men within infertile 
partnerships utilizing assisted reproductive techniques (Meeker et al., 2010).   
Our results are consistent with some in vivo and in vitro studies showing that BPA decreases 
hormone levels and expression of steroidogenic enzymes in mice and rats as well.  BPA (100 and 200 
mg/kg/day) exposure for four consecutive days has been shown to decrease testicular and plasma levels 
of testosterone as well as expression of StAR and Cyp11a1 in Wistar rats (Nakamura et al., 2010).  In 
addition, BPA (10.125mg/day) exposure for 4 consecutive days decreases levels of progesterone in 
pregnant mice (Berger et al., 2008).  Further, BPA (2.5µg/kg and 25µg/kg) exposure from gestational day 
12 to post-natal day 21 decreases testosterone production in progenitor, immature, and adult Leydig 
cells of adult Long-Evans rats (Nanjappa et al., 2012).   BPA (1-100µM) has also been shown to decrease 
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estradiol levels in cultured mouse granulosa cells after 48h exposure and BPA (10 and 100µM) decreases 
progesterone levels in cultured granulosa cells from both mice (Mlynarcikova et al., 2005) and swine 
(Grasselli et al., 2010) at 48h and 72h exposure, respectively.   Moreover, BPA (10 and 100µM) 
decreases testosterone levels in human and rat cultured Leydig cells after 3h exposure (Ye et al., 2011).  
In conjunction with these studies, our current findings provide a mechanism of action for BPA-inhibited 
steroidogenesis.  Further, our results can serve as a bridge between whole animal in vivo effects from 
BPA exposure and single cell cultures with BPA treatments, indicating that in vitro studies are 
representative of in vivo results when used in similar concentrations of BPA and over similar time 
periods. 
Overall, this study shows that BPA targets Cyp11a1 to inhibit hormone production, though these 
effects can be recovered once BPA is removed. The presence of BPA in consumer products is a great 
concern due to the numerous studies investigating the potentially adverse of effects of BPA exposure.  
However, a recent study has indicated that BPA exposure in adults can be decreased with certain 
lifestyle choices.  Urinary BPA concentrations were significantly lowered in participants when they ate 
fresh foods compared to when they ate canned and packaged foods or food from a restaurant (Rudel et 
al., 2011).  Therefore, though further studies should be conducted, in conjunction with our findings, it is 
possible to decrease exposure to BPA and recover from any adverse hormonal effects, potentially 
limiting adverse health effects associated with BPA. 
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5.6 Figures and Legends 
 
Figure 5.1 Effect of BPA exposure on sex steroid hormone production over time 
 
 
 
After exposure of antral follicles to DMSO control or BPA (1-100µg/mL) for 24-96hrs in vitro, the media 
were collected at each time-point, pooled per treatment group, and subjected to enzyme-linked 
immunosorbent assays (ELISA) for progesterone, androstenedione, testosterone, and estradiol.  The 
graphs represent means ± SEMs from at least three separate experiments.  Asterisks (*) indicate p≤0.05 
from DMSO control.  
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Figure 5.2 Effect of BPA exposure on expression of StAR and Cyp11a1 over time 
 
 
 
After exposure of antral follicles to DMSO control or BPA (1-100µg/mL) for 24-96hrs in vitro, the follicles 
were collected at each time-point and subjected to qPCR analysis for A) StAR and B) Cyp11a1 mRNA 
expression levels.  All values were normalized to β-actin as a loading control.  The graphs represent 
means ± SEMs from at least three separate experiments.  Asterisks (*) indicate p≤0.05 from DMSO 
control. 
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Figure 5.3 Effect of short BPA exposure on expression of Cyp11a1 
 
 
 
 
 
 
 
 
 
 
 
 
 
After exposure of antral follicles to DMSO control or BPA (10 or 100µg/mL) for 6-19hrs in vitro, the 
follicles were collected at each time-point and subjected to qPCR analysis for Cyp11a1 mRNA expression 
levels.  All values were normalized to β-actin as a loading control.  The graphs represent means ± SEMs 
from three separate experiments.  Asterisks (*) indicate p≤0.05 from DMSO control. 
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Figure 5.4 Effect of BPA removal on expression of StAR and Cyp11a1 over time 
 
 
 
After exposure of antral follicles to DMSO control or BPA (1 or 10µg/mL) for 20h in vitro, the media were 
removed from follicles exposed to BPA (1 or 10µg/mL) and replaced with freshly prepared 
supplemented media with DMSO.  Follicles were then cultured for 4h, 28h, 52h, or 96h more until total 
time in culture was 24h, 48h, 72h, or 96h.  At each time-point, follicles were collected and subjected to 
qPCR for analysis for A) StAR and B) Cyp11a1 mRNA expression levels.  All values were normalized to 
beta-actin as a loading control.  The graphs represent means ± SEMs from three separate experiments.  
Asterisk (*) indicates p≤0.05 from DMSO control. 
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Figure 5.5 Effect of BPA removal on sex steroid hormone production over time 
 
 
 
After exposure of antral follicles to DMSO control or BPA (1 or 10µg/mL) for 20h in vitro, the media were 
removed from follicles exposed to BPA (1 or 10µg/mL) and replaced with freshly prepared 
supplemented media with DMSO.  Follicles were then cultured for 4h, 28h, 52h, or 96h more until total 
time in culture was 24h, 48h, 72h, or 96h.  At each time-point, the media were collected and subjected 
to ELISA for progesterone, testosterone, androstenedione, and estradiol.  The graphs represent means ± 
SEMs from three separate experiments.  Asterisk (*) indicates p≤0.05 from DMSO control.  
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CHAPTER VI 
 
Summary, conclusions, and future directions 
 
6.1 Summary, Conclusions, and Future Directions 
The goal of my dissertation work was to broaden our understanding of whether BPA exposure is 
toxic to antral follicles and to determine the mechanism by which BPA induces toxicity in intact, adult, 
antral follicles. BPA is a high-volume production chemical in many consumer products and, as a result, is 
present in human tissues and fluids.  Once in the body, BPA is an endocrine disrupting chemical, capable 
of impairing the reproductive system of both males and females. BPA has been shown to impact the 
female reproductive system by impairing embryo implantation [1;2] and delaying meiotic progression in 
oocytes [3;4].  Collectively, my studies show that BPA inhibits growth of intact adult antral follicles, 
induces atresia, and reversibly inhibits steroidogenesis (Figure 6.1).    
  In chapter 3, I hypothesized that BPA inhibits antral follicle growth and steroidogenesis.  I found 
that BPA (100µg/mL) decreases follicle growth beginning at 72h and continuing throughout 120h. 
Additionally, BPA (10 and 100µg/mL) decreased levels of progesterone, dehydroepiandrosterone, 
androstenedione, testosterone, estrone, and estradiol beginning at 72h and continuing throughout 
120h.  Further, BPA (100µg/mL) decreased expression of StAR and 3β-HSD, without affecting other 
steroidogenic enzymes tested.   
Additionally, I tested the mechanism by which BPA inhibits follicle growth and steroidogenesis 
by examining the effects of co-treating antral follicles with pregnenolone and BPA on follicle growth and 
steroidogenesis.  STAR transports cholesterol into the mitochondria where CYP11A1 converts 
cholesterol to pregnenolone.  Pregnenolone is then metabolized by 3β-HSD into progesterone.  
Therefore, if BPA targets expression of StAR, Cyp11a1, and 3β-Hsd, the addition of hormone precursor 
pregnenolone should provide the necessary precursor to synthesize downstream sex steroid hormones 
normally. Co-treatment of antral follicles with BPA+pregnenolone did not protect antral follicles from 
BPA-induced follicle growth inhibition.  Additionally, co-treatment with BPA+pregnenolone did not 
protect antral follicles from BPA-induced decreases in steroidogenic enzyme expression.  However, 
BPA+pregnenolone partially protected antral follicles from BPA-induced inhibition of steroidogenesis.  
Pregnenolone co-treatment with BPA increased pregnenolone, progesterone, and DHEA-S levels 
compared to DMSO controls and maintained androstenedione and estrone levels similar to DMSO 
controls. Pregnenolone co-treatment with BPA, however, did not increase levels of testosterone and 
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estradiol production compared with DMSO controls.  Therefore, my study has shown that BPA may 
target and decrease expression of those enzymes (i.e. StAR, CYP11A1, and 3β-HSD) required to provide 
hormone precursor for sex steroid biosynthesis.  
I did not test whether BPA affects the protein levels of steroidogenic enzymes or the activities of 
the steroidogenic enzymes.  Thus, future experiments should measure protein levels and protein activity 
of the steroidogenic enzymes to determine why estradiol and testosterone levels are not protected 
from BPA induced inhibition of hormones in the presence and absence of pregnenolone.   
In chapter 4, I hypothesized that BPA inhibits adult antral follicle growth by altering cell cycle 
regulators and inducing atresia in antral follicles, independent of the genomic estrogenic pathway.  I 
found that BPA (100µg/mL) increases expression of Cdk4, Ccne1, Trp53, Bax, and Bcl2 beginning at 24h 
and continuing throughout 120h.  Additionally, I found that BPA (100µg/mL) induces atresia in adult 
antral follicles beginning at 48h and continuing throughout 120h.  Collectively, my data indicate that 
atresia occurs prior to follicle growth inhibition and, thus, atresia may lead to BPA-induced inhibition of 
follicle growth.  Future studies should investigate early markers of atresia and identify exactly when and 
how BPA induces atresia in antral follicles. 
I additionally tested the mechanism by which BPA inhibits follicle growth by examining the 
effects of BPA on estrogen receptor 1 (ESR1) and estrogen receptor 2 (ESR2), as well as co-treating 
follicles with estradiol, the estrogen receptor blocker ICI 182,780 (ICI), and treating ESR1 overexpressing 
antral follicles with BPA.  BPA is structurally similar to estradiol and has been purported to act through 
the same receptors as estradiol, such as ESR1 and ESR2. Antral follicles have both ESR1 and ESR2, thus, 
BPA may act through ESR1 and ESR2 in follicles.  In my studies, I found that BPA (100µg/mL) temporally 
regulates Esr1, increasing expression at 24h then decreasing expression by 72h.  Additionally, though 
follicle growth is not inhibited, BPA (10µg/mL) increases expression of Esr2 at 48h.  ESR2 drives 
proliferation in the granulosa cells, thus, up-regulation of Esr2 may protect these follicles from BPA-
induced growth inhibition.  Future studies should investigate if overexpression of Esr2 in the follicles 
does indeed protect antral follicles from BPA-induced growth inhibition.   
After determining that BPA affects expression of Esr1, I tested the mechanism by which BPA 
may inhibit growth and induce atresia through ESR1.  Estradiol has been shown previously to displace 
BPA from binding to ESR1 in binding assays [5] and ICI has been shown to block ESR1 activation in 
cultured mouse Hep2G cells [6]. Conversely, overexpression of Esr1 also been shown to increase 
susceptibility to endocrine disrupting chemicals that bind to ESR1 in mouse antral follicles [7]. Thus, I 
hypothesized that co-treatment with estradiol or pre-treatment with ICI would protect antral follicles 
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from BPA-induced growth inhibition. In addition, I hypothesized that overexpression of Esr1 would make 
the follicles more susceptible to BPA-induced growth inhibition.  In my studies, however, I found that 
neither co-treatment with estradiol (10nM) nor pre-treatment with ICI protects antral follicles from BPA-
induced growth inhibition.  Moreover, co-treatment with estradiol did not protect antral follicles from 
BPA-induced atresia.  Further, overexpression of Esr1 did not affect the susceptibility of antral follicles to 
BPA.   Collectively, my data suggest that BPA may not work through the genomic estrogen receptor 
pathway in antral follicles to inhibit growth and induce atresia.  Future studies should investigate if 
deleting Esr1 in the follicles will protect antral follicles from the effects of BPA.  Additionally, future 
studies should investigate if BPA inhibits follicle growth and atresia through non-genomic estrogen 
receptor pathways. 
In chapter 5, I hypothesized that BPA inhibits steroidogenesis in adult antral follicles by down-
regulating Cyp11a1, and that BPA-induced inhibition of steroidogenesis is reversible.  I found that BPA 
decreases expression of Cyp11a1 prior to decreasing expression of StAR and inhibiting hormone 
production in antral follicles.  Further, once BPA is removed from the culture, expression of Cyp11a1 
returns to control levels.  Moreover, expression of StAR never decreases and hormone levels return to 
control levels within 48h.  Collectively, my data suggest that BPA reversibly decreases steroidogenesis by 
preventing the conversion of cholesterol to pregnenolone.  Future studies should test whether removal 
of BPA is time-dependent or if the effects of BPA are reversible after removal of BPA at any time-point.  
In addition, future studies should investigate if BPA affects the transcription factors that regulate 
Cyp11a1 expression. 
 Overall, my dissertation work indicates that BPA inhibits follicle growth by inducing atresia.  
Further, BPA inhibits steroidogenesis by decreasing steroidogenic enzymes (Figure 6.1).  To induce 
atresia, BPA first up-regulates pro-atretic factor Bax.  Then, potentially as a response to BPA, expression 
of cell cycle regulators and anti-apoptotic factors increase in antral follicles to promote survival instead 
of death.  Moreover, BPA does not inhibit follicle growth or induce atresia through the genomic 
estrogenic pathway, though BPA altered expression of estrogen receptors 1 and 2 over time.  To inhibit 
steroidogenesis, BPA initially targets and decreases expression of Cyp11a1, leading to a decrease in the 
expression of StAR and hormone production.  Finally, removal of BPA after down-regulating Cyp11a1 not 
only restored expression of Cyp11a1 to control levels, but also prevented down-regulation of StAR and 
decreases in hormone production.  
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6.2 Figures and Legends 
 
Figure 6.1 Method of BPA action in adult antral follicles 
 
Depicted are two methods by which BPA affects adult antral follicles.  In the first pathway, BPA up-
regulates pro-atretic factors such as Bax and Trp53, activating the atretic pathway, followed by an 
increase in cell cycle regulators and anti-atretic factors to promote survival.  However, survival 
mechanisms fail and the follicles undergo atresia, leading to inhibition of follicle growth.  In the second 
pathway, BPA down-regulates steroidogenic enzyme Cyp11a1, leading to a decrease in expression of 
StAR and a decrease in hormone production.   
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